$ste 2023 Q2 10-K

Concept	2023 Q2	2023 Q1	2023
Revenue	$1.285B	$1.385B	$4.958B
YoY Change	11.07%	14.38%	8.13%
Cost Of Revenue	$711.1M	$796.8M	$2.798B
YoY Change	11.33%	24.68%	8.93%
Gross Profit	$573.5M	$588.1M	$2.160B
YoY Change	10.75%	2.88%	7.11%
Gross Profit Margin	44.64%	42.46%	43.56%
Selling, General & Admin	$359.1M	$335.9M	$1.299B
YoY Change	7.3%	-25.95%	-13.57%
% of Gross Profit	62.61%	57.12%	60.14%
Research & Development	$25.50M	$26.39M	$101.6M
YoY Change	3.03%	1.12%	15.51%
% of Gross Profit	4.45%	4.49%	4.7%
Depreciation & Amortization	$137.9M	$142.2M	$552.9M
YoY Change	-0.68%	-39.19%	-0.04%
% of Gross Profit	24.05%	24.18%	25.6%
Operating Expenses	$384.6M	$362.3M	$1.400B
YoY Change	7.0%	-24.48%	-11.96%
Operating Profit	$188.9M	$225.8M	$759.2M
YoY Change	19.26%	145.69%	78.38%
Interest Expense	$32.36M	-$30.28M	$108.0M
YoY Change	42.72%	48.48%	20.53%
% of Operating Profit	17.13%	-13.41%	14.22%
Other Income/Expense, Net	-$30.97M	-$30.28M	-$110.8M
YoY Change	32.09%		-0.25%
Pretax Income	$157.9M	$195.1M	$157.3M
YoY Change	17.02%	173.03%	-49.97%
Income Tax	$34.12M	$8.157M	$51.54M
% Of Pretax Income	21.61%	4.18%	32.75%
Net Earnings	$123.6M	$187.2M	$107.0M
YoY Change	11.05%	258.25%	-56.12%
Net Earnings / Revenue	9.62%	13.52%	2.16%
Basic Earnings Per Share	$1.25	$1.89	$1.07
Diluted Earnings Per Share	$1.25	$1.88	$1.07
COMMON SHARES
Basic Shares Outstanding	98.65M shares	99.28M shares	99.71M shares
Diluted Shares Outstanding	99.24M shares		100.2M shares

Concept	2023 Q2	2023 Q1	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$208.6M	$208.4M	$208.4M
YoY Change	-34.05%	-40.18%	-40.18%
Cash & Equivalents	$208.6M	$208.4M	$208.4M
Short-Term Investments
Other Short-Term Assets	$166.1M	$179.3M	$179.3M
YoY Change	12.63%	14.45%	14.45%
Inventory	$768.8M	$695.5M	$695.5M
Prepaid Expenses
Receivables	$887.8M	$928.3M	$928.3M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.031B	$2.011B	$2.011B
YoY Change	9.92%	7.05%	7.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.921B	$1.897B	$1.897B
YoY Change	22.12%	22.2%	8.97%
Goodwill	$3.887B	$3.879B
YoY Change	-10.06%	-11.92%
Intangibles	$2.865B	$2.956B
YoY Change	-10.27%	-11.2%
Long-Term Investments
YoY Change
Other Assets	$80.04M	$78.15M	$78.15M
YoY Change	14.08%	10.59%	10.59%
Total Long-Term Assets	$8.753B	$8.810B	$8.810B
YoY Change	-6.28%	-7.69%	-7.69%
TOTAL ASSETS
Total Short-Term Assets	$2.031B	$2.011B	$2.011B
Total Long-Term Assets	$8.753B	$8.810B	$8.810B
Total Assets	$10.78B	$10.82B	$10.82B
YoY Change	-3.61%	-5.27%	-5.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$260.7M	$279.6M	$279.6M
YoY Change	13.84%	23.87%	23.87%
Accrued Expenses	$332.8M	$317.8M	$298.5M
YoY Change	4.76%	3.68%	-8.86%
Deferred Revenue
YoY Change
Short-Term Debt	$63.44M	$60.00M	$0.00
YoY Change	-57.99%	-58.01%
Long-Term Debt Due	$63.44M	$60.00M	$60.00M
YoY Change	-57.99%	-58.01%	-58.01%
Total Short-Term Liabilities	$886.9M	$861.8M	$861.8M
YoY Change	-2.36%	-6.55%	-6.55%
LONG-TERM LIABILITIES
Long-Term Debt	$2.860B	$3.019B	$3.019B
YoY Change	0.48%	2.48%	2.48%
Other Long-Term Liabilities	$859.0M	$854.2M	$854.2M
YoY Change	1075.48%	1030.17%	270.35%
Total Long-Term Liabilities	$3.719B	$3.873B	$3.873B
YoY Change	27.39%	28.19%	21.94%
TOTAL LIABILITIES
Total Short-Term Liabilities	$886.9M	$861.8M	$861.8M
Total Long-Term Liabilities	$3.719B	$3.873B	$3.873B
Total Liabilities	$4.606B	$4.735B	$4.735B
YoY Change	-3.42%	-2.96%	-3.2%
SHAREHOLDERS EQUITY
Retained Earnings	$1.981B	$1.912B
YoY Change	-3.71%	-4.39%
Common Stock	$4.498B	$4.486B
YoY Change	-5.08%	-5.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.178B	$6.087B	$6.087B
YoY Change
Total Liabilities & Shareholders Equity	$10.78B	$10.82B	$10.82B
YoY Change	-3.61%	-5.27%	-5.27%

Concept	2023 Q2	2023 Q1	2023
OPERATING ACTIVITIES
Net Income	$123.6M	$187.2M	$107.0M
YoY Change	11.05%	258.25%	-56.12%
Depreciation, Depletion And Amortization	$137.9M	$142.2M	$552.9M
YoY Change	-0.68%	-39.19%	-0.04%
Cash From Operating Activities	$281.1M	$215.8M	$756.9M
YoY Change	21.31%	25.66%	10.53%
INVESTING ACTIVITIES
Capital Expenditures	$66.60M	$71.45M	$362.0M
YoY Change	-42.55%	-197.78%	25.87%
Acquisitions	$0.00		$42.57M
YoY Change			-92.27%
Other Investing Activities	$5.000K	-$6.129M	-$21.36M
YoY Change	-99.92%	-103.68%
Cash From Investing Activities	-$66.60M	-$77.58M	-$383.3M
YoY Change	-39.14%	-182.9%	-42.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$306.7M
YoY Change			-649.93%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-213.6M	-191.9M	-498.7M
YoY Change	51.07%	-30.1%	-530.56%
NET CHANGE
Cash From Operating Activities	281.1M	215.8M	756.9M
Cash From Investing Activities	-66.60M	-77.58M	-383.3M
Cash From Financing Activities	-213.6M	-191.9M	-498.7M
Net Change In Cash	896.0K	-53.73M	-125.1M
YoY Change	-102.8%	477.64%	-197.9%
FREE CASH FLOW
Cash From Operating Activities	$281.1M	$215.8M	$756.9M
Capital Expenditures	$66.60M	$71.45M	$362.0M
Free Cash Flow	$214.5M	$144.3M	$395.0M
YoY Change	85.24%	-41.03%	-0.57%

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001757898
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	98650238	shares
CY2022Q3	dei	Entity Public Float EntityPublicFloat	16561000000	usd
CY2022Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	14250000	usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-38848
CY2023	dei	Entity Registrant Name EntityRegistrantName	STERIS plc
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	L2
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1455064
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	70 Sir John Rogerson's Quay,
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Dublin 2,
CY2023	dei	Entity Address Country EntityAddressCountry	IE
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	D02 R296
CY2023	dei	Country Region CountryRegion	353
CY2023	dei	City Area Code CityAreaCode	1
CY2023	dei	Local Phone Number LocalPhoneNumber	232 2000
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Public Float EntityPublicFloat	16561000000	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	98650238	shares
CY2023	dei	Auditor Firm AuditorFirmId	42
CY2023	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2023	dei	Auditor Location AuditorLocation	Cleveland, Ohio
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	208357000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	348320000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	23427000	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	24371000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	928315000	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	799041000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	695493000	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	574999000	usd
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	179277000	usd
CY2022Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	156637000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	2011442000	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	1878997000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1705512000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1552576000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	191741000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	188480000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	3879219000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	4404343000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2955780000	usd
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3328537000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	78145000	usd
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	70661000	usd
CY2023Q1	us-gaap	Assets Assets	10821839000	usd
CY2022Q1	us-gaap	Assets Assets	11423594000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	279620000	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	225737000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	43804000	usd
CY2022Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	26873000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	125642000	usd
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	183721000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	34961000	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	36472000	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	60000000	usd
CY2022Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	142875000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	317817000	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	306544000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	861844000	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	922222000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3018655000	usd
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2945481000	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	617538000	usd
CY2022Q1	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	780619000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	160493000	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	155056000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	76137000	usd
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	75579000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	4734667000	usd
CY2022Q1	us-gaap	Liabilities Liabilities	4878957000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	98629000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	98629000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	100067000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	100067000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	4486375000	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	4742920000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1911533000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1999244000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-320710000	usd
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-209808000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	6077198000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	6532356000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	9974000	usd
CY2022Q1	us-gaap	Minority Interest MinorityInterest	12281000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6087172000	usd
CY2021Q1	ste	Deferred Consideration DeferredConsideration	1194000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6544637000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10821839000	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11423594000	usd
CY2023	us-gaap	Revenues Revenues	4957839000	usd
CY2022	us-gaap	Revenues Revenues	4585064000	usd
CY2021	us-gaap	Revenues Revenues	3107519000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2798147000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2568702000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1764419000	usd
CY2023	us-gaap	Gross Profit GrossProfit	2159692000	usd
CY2022	us-gaap	Gross Profit GrossProfit	2016362000	usd
CY2021	us-gaap	Gross Profit GrossProfit	1343100000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1298876000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1502752000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	731320000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	490565000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	101581000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	87944000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	66326000	usd
CY2023	us-gaap	Restructuring Costs RestructuringCosts	485000	usd
CY2022	us-gaap	Restructuring Costs RestructuringCosts	48000	usd
CY2021	us-gaap	Restructuring Costs RestructuringCosts	-2914000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1891507000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1590744000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	794732000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	268185000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	425618000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	548368000	usd
CY2023	us-gaap	Interest Expense InterestExpense	107989000	usd
CY2022	us-gaap	Interest Expense InterestExpense	89593000	usd
CY2021	us-gaap	Interest Expense InterestExpense	37180000	usd
CY2023	ste	Fair Value Adjustment Related To Convertible Debt Liability FairValueAdjustmentRelatedToConvertibleDebtLiability	0	usd
CY2022	ste	Fair Value Adjustment Related To Convertible Debt Liability FairValueAdjustmentRelatedToConvertibleDebtLiability	27806000	usd
CY2021	ste	Fair Value Adjustment Related To Convertible Debt Liability FairValueAdjustmentRelatedToConvertibleDebtLiability	0	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2848000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6284000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6345000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-110837000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-111115000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-30835000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	157348000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	314503000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	517533000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	51535000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	71633000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	120663000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	105813000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	242870000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	396870000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1217000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1018000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-530000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	107030000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	243888000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	397400000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.07
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.50
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.66
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.07
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.48
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.63
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.84
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.69
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.57
CY2023	us-gaap	Profit Loss ProfitLoss	105813000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	242870000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	396870000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1217000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1018000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-530000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	107030000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	243888000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	397400000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	521000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	507000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	667000	usd
CY2023	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-1264000	usd
CY2022	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	6795000	usd
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	1294000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-109638000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-155360000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	172926000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-110902000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-148565000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	174220000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3872000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	95323000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	571620000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	105813000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	242870000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	396870000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	552897000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	553104000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	219237000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-185913000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-106620000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4240000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	38951000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	57660000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	25966000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-22193000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-15117000	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1982000	usd
CY2023	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	67000	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	874000	usd
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-2030000	usd
CY2023	ste	Fair Value Adjustment Related To Convertible Debt Liability FairValueAdjustmentRelatedToConvertibleDebtLiability	0	usd
CY2022	ste	Fair Value Adjustment Related To Convertible Debt Liability FairValueAdjustmentRelatedToConvertibleDebtLiability	27806000	usd
CY2021	ste	Fair Value Adjustment Related To Convertible Debt Liability FairValueAdjustmentRelatedToConvertibleDebtLiability	0	usd
CY2023	ste	Amortization Of Inventory Fair Value Adjustments AmortizationOfInventoryFairValueAdjustments	7363000	usd
CY2022	ste	Amortization Of Inventory Fair Value Adjustments AmortizationOfInventoryFairValueAdjustments	66663000	usd
CY2021	ste	Amortization Of Inventory Fair Value Adjustments AmortizationOfInventoryFairValueAdjustments	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	490565000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	24832000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	21639000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-24273000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	133304000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	51969000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-12076000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	123921000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	102922000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3769000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	24086000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7126000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-458000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	53342000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	14887000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-7213000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-22054000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-16398000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	9916000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	756947000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	684811000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	689640000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	361969000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	287563000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	239262000	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	14587000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1741000	usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	569000	usd
CY2023	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	6624000	usd
CY2022	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	169712000	usd
CY2021	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	518000	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	4400000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	42572000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	550449000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	909192000	usd
CY2023	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	usd
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	usd
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	2392000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-383330000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-666559000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1154159000	usd
CY2023	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	1350000000	usd
CY2021	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	650000000	usd
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	550000000	usd
CY2023	ste	Repayments Of Term Loans RepaymentsOfTermLoans	156875000	usd
CY2022	ste	Repayments Of Term Loans RepaymentsOfTermLoans	345000000	usd
CY2021	ste	Repayments Of Term Loans RepaymentsOfTermLoans	0	usd
CY2023	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	91000000	usd
CY2022	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	721284000	usd
CY2021	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	35000000	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	371361000	usd
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2023	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	241657000	usd
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-190174000	usd
CY2021	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-30461000	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	17472000	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	12846000	usd
CY2023	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	1471000	usd
CY2022	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	32679000	usd
CY2021	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	2395000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	308565000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	55777000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	14646000	usd
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	183498000	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	163169000	usd
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	133837000	usd
CY2023	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	794000	usd
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	997000	usd
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	4179000	usd
CY2023	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	usd
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	3672000	usd
CY2021	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	2258000	usd
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	1828000	usd
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	10071000	usd
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	26726000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-498718000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	115830000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	345620000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-14862000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-6293000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19849000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-139963000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	127789000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-99050000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	348320000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	220531000	usd
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	319581000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	208357000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	348320000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	220531000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	396870000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-174220000	usd
CY2021	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	14646000	usd
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	52491000	usd
CY2021	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.57
CY2021	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	133837000	usd
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	4179000	usd
CY2021	ste	Noncontrolling Interest Increase From Contributions To Noncontrolling Interest Holders NoncontrollingInterestIncreaseFromContributionsToNoncontrollingInterestHolders	2258000	usd
CY2021	ste	Increase Decrease In Noncontrolling Interests Other IncreaseDecreaseInNoncontrollingInterestsOther	-81000	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3891468000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	242870000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	148565000	usd
CY2022	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	55777000	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	67499000	usd
CY2022	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.69
CY2022	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	163169000	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2689317000	usd
CY2022	ste	Consideration Related To Equity Component Of Cantel Convertible Debt ConsiderationRelatedToEquityComponentOfCantelConvertibleDebt	175555000	usd
CY2022	ste	Consideration Related To Cantel Equity Compensation Programs ConsiderationRelatedToCantelEquityCompensationPrograms	18173000	usd
CY2022	ste	Reclassification To Cantel Convertible Debt Premium Liability ReclassificationToCantelConvertibleDebtPremiumLiability	175555000	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	997000	usd
CY2022	ste	Noncontrolling Interest Increase From Contributions To Noncontrolling Interest Holders NoncontrollingInterestIncreaseFromContributionsToNoncontrollingInterestHolders	3672000	usd
CY2022	ste	Increase Decrease In Noncontrolling Interests Other IncreaseDecreaseInNoncontrollingInterestsOther	-146000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6544637000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	105813000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	110902000	usd
CY2023	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	308565000	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	40777000	usd
CY2023	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.84
CY2023	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	183498000	usd
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	794000	usd
CY2023	ste	Increase Decrease In Noncontrolling Interests Other IncreaseDecreaseInNoncontrollingInterestsOther	296000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6087172000	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nature of Operations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare, life sciences and dental products and services. We offer our Customers a unique mix of innovative consumable products, such as detergents, endoscopy accessories, barrier products, and other products and services, including: equipment installation and maintenance, microbial reduction of medical devices, dental instruments and tools, instrument and scope repair, laboratory testing services, outsourced reprocessing, and capital equipment products, such as sterilizers and surgical tables, automated endoscope reprocessors, and connectivity solutions such as operating room (“OR”) integrati</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate and report in four reportable business segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. We describe our business segments in Note 11 titled, "Business Segment Information."</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year ends on March 31. References in this Annual Report to a particular "year," "fiscal," "fiscal year," or "year-end" mean our fiscal year. The significant accounting policies applied in preparing the accompanying consolidated financial statements of the Company are summarized below.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the consolidation method to report our investment in our subsidiaries. Therefore, the accompanying consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. We eliminate intercompany accounts and transactions when we consolidate these accounts. Investments in equity of unconsolidated affiliates, over which the Company has significant influence, but not control, over the financial and operating polices, are accounted for primarily using the equity method. These investments are immaterial to the Company's consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We make certain estimates and assumptions when preparing financial statements according to U.S. GAAP that affect the reported amounts of assets and liabilities at the financial statement dates and the reported amounts of revenues and expenses during the periods presented. These estimates and assumptions involve judgments with respect to many factors that are difficult to predict and are beyond our control. Actual results could be materially different from these estimates. We revise the estimates and assumptions as new information becomes available.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents and Supplemental Cash Flow Information. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are all highly liquid investments with a maturity of three months or less when purchased. We invest our excess cash in short-term instruments including money market funds, money market deposit accounts, bank savings accounts, and time deposits with major banks and financial institutions. We select investments in accordance with the criteria established in our investment policy. Our investment policy specifies, among other things, maturity, credit quality and concentration restrictions with the objective of preserving capital and maintaining adequate liquidity.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information supplementing our Consolidated Statements of Cash Flows is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:55.263%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.692%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Years Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">108,470</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,696 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,257 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">254,661</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,382 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,646 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received during the year for income tax refunds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,315</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,605 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,631 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition and Associated Liabilities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when obligations under the terms of the contract are satisfied and control of the promised products or services have transferred to the Customer. Revenues are measured at the amount of consideration that we expect to be paid in exchange for the products or services. Product revenue is recognized when control passes to the Customer, which is generally based on contract or shipping terms. Service revenue is recognized when the Customer benefits from the service, which occurs either upon completion of the service or as it is provided to the Customer. Our Customers include end users as well as dealers and distributors who market and sell our products. Our revenue is not contingent upon resale by the dealer or distributor, and we have no further obligations related to bringing about resale. Our standard return and restocking fee policies are applied to sales of products. Shipping and handling costs charged to Customers are included in Product revenues. The associated expenses are treated as fulfillment costs and are included in Cost of revenues. Revenues are reported net of sales and value-added taxes collected from Customers.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have individual Customer contracts that offer discounted pricing. Dealers and distributors may be offered sales incentives in the form of rebates. We reduce revenue for discounts and estimated returns, rebates, and other similar allowances in the same period the related revenues are recorded. The reduction in revenue for these items is estimated based on historical experience and trend analysis to the extent that it is probable that a significant reversal of revenue will not occur. Estimated returns are recorded gross on the Consolidated Balance Sheets.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In transactions that contain multiple performance obligations, such as when products, maintenance services, and other services are combined, we recognize revenue as each product is delivered or service is provided to the Customer. We allocate the total arrangement consideration to each performance obligation based on its relative standalone selling price, which is the price for the product or service when it is sold separately.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment terms vary by the type and location of the Customer and the products or services offered. Generally, the time between when revenue is recognized and when payment is due is not significant. We do not evaluate whether the selling price contains a financing component for contracts that have a duration of less than one year.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not capitalize sales commissions as substantially all of our sales commission programs have an amortization period of one year or less.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain costs to fulfill a contract are capitalized and amortized over the term of the contract if they are recoverable, directly related to a contract and generate resources that we will use to fulfill the contract in the future. At March 31, 2023, assets related to costs to fulfill a contract were not material to our consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 11 titled, "Business Segment Information" for disaggregation of revenue.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Revenues</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenues consist of revenues generated from sales of consumables and capital equipment. These contracts are primarily based on a Customer’s purchase order and may include a Distributor, Dealer or Group Purchasing Organization ("GPO") agreement.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue for sales of product when control passes to the Customer, which generally occurs either when the products are shipped or when they are received by the Customer. Revenue related to capital equipment products is deferred until installation is complete if the capital equipment and installation are highly integrated and form a single performance obligation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Revenues</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our Healthcare and Life Sciences segments, service revenues include revenue generated from parts and labor associated with the maintenance, repair and installation of capital equipment. These contracts are primarily based on a Customer’s purchase order and may include a Distributor, Dealer, or GPO agreement. For maintenance, repair and installation of capital equipment, revenue is recognized upon completion of the service. Healthcare service revenues also include outsourced reprocessing services and instrument repairs. Contracts for outsourced reprocessing services are primarily based on an agreement with a Customer, ranging in length from several months to 15 years. Outsourced reprocessing services revenue is recognized ratably over the contract term using a time-based input measure, adjusted for volume and other performance metrics, to the extent that it is probable that a significant reversal of revenue will not occur. Contracts for instrument repairs are primarily based on a Customer’s purchase order, and the associated revenue is recognized upon completion of the repair. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer preventive maintenance and separately priced extended warranty agreements to our Customers, which require us to maintain and repair our products over the duration of the contract. Generally, these contract terms are cancellable without penalty and range from one to five years. Amounts received under these Customer contracts are initially recorded as a service liability and are recognized as service revenue ratably over the contract term using a time-based input measure. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our Applied Sterilization Technologies segment, service revenues include contract sterilization and laboratory services. Sales contracts for contract sterilization and laboratory services are primarily based on a Customer’s purchase order and associated Customer agreement and revenues are generally recognized upon completion of the service.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Liabilities</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments received from Customers are based on invoices or billing schedules as established in contracts with Customers. Deferred revenue is recorded when payment is received in advance of performance under the contract. Deferred revenue is recognized as revenue upon completion of the performance obligation, which generally occurs within one year. During fiscal 2023, we recognized revenue of $78,752 that was included in our contract liability balance at the beginning of the period. During fiscal 2022, we recognized revenue of $46,760 that was included in our contract liability balance at the beginning of the period.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 7 titled, "Additional Consolidated Balance Sheet Information" for deferred revenue balances.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Liabilities</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments received in advance of performance for cancellable preventive maintenance and separately priced extended warranty contracts are recorded as service liabilities. Service liabilities are recognized as revenue as performance is rendered under the contract. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 7 titled, "Additional Consolidated Balance Sheet Information" for service liability balances.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations reflect only the performance obligations related to agreements for which we have a firm commitment from a Customer to purchase, and exclude variable consideration related to unsatisfied performance obligations. With regard to products, these remaining performance obligations include capital equipment and consumable orders which have not shipped. With regard</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to service, these remaining performance obligations primarily include installation, certification, and outsourced reprocessing services. As of March 31, 2023, the transaction price allocated to remaining performance obligations was approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1,553,461</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We expect to recognize approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the transaction price within one year and approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> beyond one year. The remainder has yet to be scheduled for delivery.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Accounts receivable are presented at their face amount, less allowances for sales returns and uncollectible accounts. Accounts receivable consist of amounts billed and currently due from Customers and amounts earned but unbilled. We generally obtain and perfect security interest in products sold in the United States when we have a concern with the Customer's risk profile.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain an allowance for uncollectible accounts receivable for estimated losses in the collection of amounts owed by Customers. We estimate the allowance based on analyzing a number of factors, including amounts written off historically, Customer payment practices, and general economic conditions. We also analyze significant Customer accounts on a regular basis and record a specific allowance when we become aware of a specific Customer’s inability to pay. As a result, the related accounts receivable are reduced to an amount that we reasonably believe is collectible.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain an allowance for sales returns based upon known returns and estimated returns for both capital equipment and consumables. We estimate returns of capital equipment and consumables based upon recent historical experience.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> net. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of their cost and net realizable value determined by the first-in, first-out (“FIFO”) cost method. Inventory costs include material, labor, and overhead.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review inventory on an ongoing basis, considering factors such as deterioration, obsolescence, and other items. We record an allowance for estimated losses when the facts and circumstances indicate that particular inventories will not be usable. If future market conditions vary from those projected, and our estimates prove to be inaccurate, we may be required to write-down inventory values and record an adjustment to Cost of revenues.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant, and Equipment. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our property, plant, and equipment consists of land and land improvements, buildings and leasehold improvements, machinery and equipment, information systems, radioisotope (cobalt-60), and construction in progress. Property, plant, and equipment are presented at cost less accumulated depreciation and depletion. We capitalize additions and improvements. Repairs and maintenance are charged to expense as they are incurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land is not depreciated and construction in progress is not depreciated until placed in service. Depreciation of most assets is computed on the cost less the estimated salvage value by using the straight-line method over the estimated remaining useful lives. Depletion of radioisotope is computed using the annual decay factor of the material, which is similar to the sum-of-the-years-digits method.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally depreciate or deplete property, plant, and equipment over the useful lives presented in the following table:</span></div><div style="margin-bottom:6pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Useful Life<br/>(years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land improvements</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-40</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-50</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-20</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information Systems</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-20</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radioisotope (cobalt-60)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we sell, retire, or dispose of property, plant, and equipment, we remove the asset’s cost and accumulated depreciation from our Consolidated Balance Sheet. We recognize the net gain or loss on the sale or disposition in the Consolidated Statements of Income in the period when the transaction occurs.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize interest costs incurred during the construction of long-lived assets. We capitalized interest costs of $6,366 and $3,886 for the years ended March 31, 2023 and 2022, respectively. Total interest expense for the years ended March 31, 2023, 2022, and 2021 was $107,989, $89,593, and $37,180, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Identifiable Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our identifiable intangible assets include product technology rights, trademarks, licenses, non-compete agreements, and Customer and vendor relationships. We record these assets at cost, or when acquired as part of a business acquisition, at estimated fair value. Determining the fair value of identifiable intangible requires management’s judgment and often involves the use of significant estimates and assumptions, including assumptions with respect to forecasted revenue growth rates, forecasted profit margins, and Customer attrition rates, among other items. We generally amortize identifiable intangible assets over periods ranging from 5 to 20 years using the straight-line method. Our intangible assets also include indefinite lived assets including certain trademarks and tradenames that were acquired in connection with business combinations. These assets are tested at least annually for impairment. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Investments in marketable securities are stated at fair value and are included in Other assets on the Consolidated Balance Sheets. Changes in the fair value of these investments are recorded in the Interest income and miscellaneous expense (income) line of the Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Impairment Losses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Property, plant, equipment, and identifiable intangible assets are reviewed for impairment when indicators of impairment exist and circumstances indicate that the carrying value of such assets may not be recoverable. Impaired assets are recorded at the lower of carrying value or estimated fair value. We monitor for such indicators on an ongoing basis and if an impairment exists, we record the loss in the Consolidated Statements of Income during that period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Retirement Obligations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We incur retirement obligations for certain assets. We record initial liabilities for the asset retirement obligations ("ARO") at fair value. Recognition of ARO includes: estimating the present value of a liability and offsetting asset, the subsequent accretion of that liability and depletion of the asset, and a periodic review of the ARO liability estimates and discount rates used in the analysis. We provide additional information about our asset retirement obligations in Note 5 titled, “Property, Plant, and Equipment.”</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions of Business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Assets acquired and liabilities assumed in a business combination are accounted for at fair value on the date of acquisition. Costs related to the acquisition are expensed as incurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We perform our annual impairment test for goodwill in the third quarter of each year. We may consider qualitative indicators of the fair value of a reporting unit when it is unlikely that a reporting unit has impaired goodwill. We may also utilize a discounted cash flow analysis that requires certain assumptions and estimates be made regarding market conditions and our future profitability. We review the book value compared to the fair value at the reporting unit level. We calculate the fair value of our reporting units based on the present value of estimated future cash flows. Management's judgment is necessary to evaluate the impact of operating and macroeconomic changes and to estimate future cash flows to measure fair value. Assumptions used in our impairment evaluations, such as forecasted growth rates and cost of capital, are consistent with internal projections, strategic plans, and operating plans. We believe such assumptions and estimates are also comparable to those that would be used by other marketplace participants.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Self-Insurance Liabilities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We record a liability for self-insured risks that we retain for general and product liabilities, workers’ compensation, and automobile liabilities based on actuarial calculations. We use our historical loss experience and actuarial methods to calculate the liability. This liability includes estimates for both losses and incurred but not reported claims. We review the assumptions used to calculate the estimated liability at least annually to evaluate the adequacy of the amount recorded. We maintain insurance policies to cover losses greater than our estimated liability, which are subject to the terms and conditions of those policies. We are also self-insured for certain employee medical claims. We estimate a liability for incurred but not reported claims based upon recent claims experience.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Benefit Plans. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We sponsor defined benefit pension plans. We also sponsor a post-retirement benefits plan for certain former employees. We determine our costs and obligations related to these plans by evaluating input from third-party professional advisers. These costs and obligations are affected by assumptions including the discount rate, expected long-term rate of return on plan assets, the annual rate of change in compensation for eligible employees, estimated changes in costs of healthcare benefits, and other factors. We review the assumptions used on an annual basis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize an asset for the overfunded status or a liability for the underfunded status of defined benefit pension and post-retirement benefits plans in our consolidated balance sheets. This amount is measured as the difference between the fair value of plan assets and the benefit obligation (the projected benefit obligation for pension plans and the accumulated post-retirement benefit obligation for other post-retirement benefit plans). Changes in the funded status of the plans are recorded in other comprehensive income in the year they occur. We measure plan assets and obligations as of the balance sheet date. We provide additional information about our pension and other post-retirement benefits plans in Note 9 titled, “Benefit Plans.”</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Except for long-term debt, our financial instruments are highly liquid or have short-term maturities. We provide additional information about the fair value of our financial instruments in Note 17 titled, “Fair Value Measurements.”</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Most of our operations use their local currency as their functional currency. Financial statements of subsidiaries are translated into U.S. dollars using the exchange rate at each balance sheet date for assets and liabilities and a weighted average exchange rate for each period for revenues, expenses, gains and losses. Translation adjustments for subsidiaries whose local currency is their functional currency are recorded as a component of accumulated other comprehensive income (loss) within equity. Transaction gains and losses resulting from fluctuations in currency exchange rates on transactions denominated in currencies other than the functional currency are recognized as incurred in the accompanying Consolidated Statements of Income, except for certain intercompany balances designated as long-term in nature.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward and Swap Contracts. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We enter into foreign currency forward contracts to hedge assets and liabilities denominated in foreign currencies, including intercompany transactions.We may also enter into commodity swap contracts to hedge price changes in nickel that impact raw materials included in our Cost of revenues. We may also hold forward foreign exchange contracts to hedge a portion of our expected non-U.S. dollar denominated earnings against our reporting currency, the U.S. dollar. We do not use derivative financial instruments for speculative purposes. These contracts are marked to market, with gains and losses recognized within Selling, general, and administrative expenses or Cost of revenues in the accompanying Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warranty.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Warranties are provided on the sale of certain of our products and services and an accrual for estimated future claims is recorded at the time revenue is recognized. We estimate warranty expense based primarily on historical warranty claim experience.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We record shipping and handling costs in costs of revenues. Shipping and handling costs charged to Customers are recorded as revenues in the period the product revenues are recognized.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Costs incurred for communicating, advertising and promoting our products are generally expensed when incurred as a component of Selling, general, and administrative expenses. We incurred $21,668, $15,599, and $6,795 of advertising costs during the years ended March 31, 2023, 2022, and 2021, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We incur research and development costs associated with commercial products and expense these costs as incurred. If a Customer reimburses us for research and development costs, the costs are charged to the related contracts as costs of revenues.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We defer income taxes for all temporary differences between pre-tax financial and taxable income and between the book and tax basis of assets and liabilities. We record valuation allowances to reduce net deferred tax assets to an amount that we expect will more-likely-than-not be realized. In making such a determination, we consider all available information, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies, and if applicable, any carryback claims that can be filed. In the event we were to determine that we would be able to realize our deferred income tax assets in the future in excess of their net recorded amount, we would make an adjustment to the valuation allowance which would reduce the provision for income taxes and the effective tax rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate uncertain tax positions in accordance with a two-step process. The first step is recognition: The determination of whether or not it is more-likely-than-not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, we presume that the position will be examined by the appropriate tax authority and that the tax authority will have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not threshold is measured to determine the amount of benefit to recognize in the financial statements. The measurement process requires the determination of the range of possible settlement amounts and the probability of achieving each of the possible settlements. The tax position is measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. No tax benefits are recognized for positions that do not meet the more-likely-than-not threshold. Tax positions that previously failed to meet the more-likely-than-not threshold are recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not recognition threshold are derecognized in the first subsequent financial reporting period in which the threshold is no longer met. We describe income taxes further in Note 8 titled, “Income Taxes.”</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We describe share-based compensation in Note 14 titled, “Share-Based Compensation.” We measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award. We record liability awards at fair value each reporting period and the change in fair value is reflected as share-based compensation expense in our Consolidated Statements of Income. The expense is classified as Cost of revenues, Selling, general, and administrative expenses or Research and development expenses in a manner consistent with the employee’s compensation and benefits. These costs are recognized in the Consolidated Statements of Income over the period during which an employee is required to provide service in exchange for the award. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We recognize restructuring expenses as incurred. Asset impairment and accelerated depreciation expenses primarily relate to inventory write-downs for rationalized products and adjustments in the carrying value of the related facilities and machinery and equipment to their estimated fair value. In addition, the remaining useful lives of other property, plant, and equipment associated with the related operations are re-evaluated based on the respective restructuring plan, which may result in the acceleration of depreciation and amortization of certain assets. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Impacting the Company </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recently Issued Accounting Standards Impacting the Company are presented in the following table:</span></div><div style="margin-bottom:6pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:14.136%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.107%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.331%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.609%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Issuance</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Adoption</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect on the financial statements or other significant matters</span></td></tr><tr><td colspan="27" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standards that have been adopted in fiscal 2023.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2021-08 "Business Combinations (Topic 805) Accounting for Contract Assets and Contract Liabilities from Contracts with Customers."</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The standard provides guidance to improve the accounting for acquired revenue contracts with Customers in a business combination by addressing diversity in practice and inconsistency related to the recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. </span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Quarter Fiscal 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We adopted this standard effective April 1, 2022 with no material impact to our consolidated financial statements.</span></td></tr><tr><td colspan="27" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standards that have not yet been adopted.</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2022-04 "Liabilities - Supplier Finance Programs (Subtopic 405-50) Disclosure of Supplier Finance Program Obligations</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The standard provides guidance to enhance the transparency of disclosures for entities that utilize supplier finance programs to include information about the key terms of the programs and present a rollforward of any obligations under the program where those obligations are presented in the balance sheet.</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are in the process of evaluating the impact that the standard will have on our consolidated financial statements.</span></td></tr></table></div>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We make certain estimates and assumptions when preparing financial statements according to U.S. GAAP that affect the reported amounts of assets and liabilities at the financial statement dates and the reported amounts of revenues and expenses during the periods presented. These estimates and assumptions involve judgments with respect to many factors that are difficult to predict and are beyond our control. Actual results could be materially different from these estimates. We revise the estimates and assumptions as new information becomes available.</span>
CY2023	ste	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Lease Right Of Use Assets Net BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLeaseRightOfUseAssetsNet	0	usd
CY2023	us-gaap	Interest Paid InterestPaid	108470000	usd
CY2022	us-gaap	Interest Paid InterestPaid	84696000	usd
CY2021	us-gaap	Interest Paid InterestPaid	36257000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	254661000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	138382000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	109646000	usd
CY2023	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	2315000	usd
CY2022	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	4605000	usd
CY2021	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	4631000	usd
CY2023	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	78752000	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	46760000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1553461000	usd
CY2023	ste	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Other Assets BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets	0	usd
CY2023	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	6366000	usd
CY2022	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	3886000	usd
CY2023	us-gaap	Interest Costs Incurred InterestCostsIncurred	107989000	usd
CY2022	us-gaap	Interest Costs Incurred InterestCostsIncurred	89593000	usd
CY2021	us-gaap	Interest Costs Incurred InterestCostsIncurred	37180000	usd
CY2023	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Impairment Losses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Property, plant, equipment, and identifiable intangible assets are reviewed for impairment when indicators of impairment exist and circumstances indicate that the carrying value of such assets may not be recoverable. Impaired assets are recorded at the lower of carrying value or estimated fair value. We monitor for such indicators on an ongoing basis and if an impairment exists, we record the loss in the Consolidated Statements of Income during that period.</span>
CY2023	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Intangibles BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles	0	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	21668000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	15599000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	6795000	usd
CY2023	ste	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Convertible Debt Par Value BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConvertibleDebtParValue	0	usd
CY2022Q1	dei	Entity Number Of Employees EntityNumberOfEmployees	3700
CY2022Q1	ste	Cantel Acquisition Assumed Debt Obligations CantelAcquisitionAssumedDebtObligations	721284000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	490565000	usd
CY2023	ste	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Cash BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCash	0	usd
CY2023	ste	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Accounts Receivable BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable	0	usd
CY2023	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Inventory BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory	0	usd
CY2023	ste	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Long Term Lease Obligations BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermLeaseObligations	0	usd
CY2023	ste	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Long Term Indebtedness BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermIndebtedness	0	usd
CY2023	ste	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Net Assets Acquired BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired	0	usd
CY2022Q1	ste	Contingent Consideration Liability Assumed In Cantel Combination ContingentConsiderationLiabilityAssumedInCantelCombination	25000000	usd
CY2022	ste	Net Sales Attributable To Cantel NetSalesAttributableToCantel	974408000	usd
CY2022	ste	Operating Loss Income Attributable To Cantel OperatingLossIncomeAttributableToCantel	41757000	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	4790161000	usd
CY2021	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	4190244000	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	449382000	usd
CY2021	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	5849000	usd
CY2022Q1	ste	Deferred Consideration DeferredConsideration	50000	usd
CY2023Q1	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	4863000	usd
CY2022Q1	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	427035000	usd
CY2021Q1	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	197344000	usd
CY2023	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	24196000	usd
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	205788000	usd
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	35634000	usd
CY2021Q1	us-gaap	Goodwill Goodwill	3026049000	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1522381000	usd
CY2022	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-15819000	usd
CY2022	ste	Goodwill Decrease From Divestitures GoodwillDecreaseFromDivestitures	-7000000	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-121268000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	4404343000	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	7024000	usd
CY2023	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	22088000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	490565000	usd
CY2023	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	2358000	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-61313000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	3879219000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	490565000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4181098000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1225318000	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4185318000	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	856781000	usd
CY2023Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	14250000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	379752000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	368698000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	86512000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	369358000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	363499000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	354672000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	348506000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	343510000	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	239081000	usd
CY2022Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	195035000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	6502000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	97756000	usd
CY2022Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	76021000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	404238000	usd
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	334880000	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	45582000	usd
CY2022Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	30937000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	695493000	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	574999000	usd
CY2023Q1	us-gaap	Land Land	84313000	usd
CY2022Q1	us-gaap	Land Land	84015000	usd
CY2023Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	691933000	usd
CY2022Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	654851000	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	994188000	usd
CY2022Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	903649000	usd
CY2023Q1	ste	Computer Softwareand Hardwaregross ComputerSoftwareandHardwaregross	247873000	usd
CY2022Q1	ste	Computer Softwareand Hardwaregross ComputerSoftwareandHardwaregross	222620000	usd
CY2023Q1	us-gaap	Materials Supplies And Other MaterialsSuppliesAndOther	637920000	usd
CY2022Q1	us-gaap	Materials Supplies And Other MaterialsSuppliesAndOther	597641000	usd
CY2023Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	478316000	usd
CY2022Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	356013000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3134543000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2818789000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1429031000	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1266213000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1705512000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1552576000	usd
CY2023	us-gaap	Depreciation Depreciation	173145000	usd
CY2022	us-gaap	Depreciation Depreciation	184406000	usd
CY2021	us-gaap	Depreciation Depreciation	132725000	usd
CY2022Q1	ste	Term Loan Current Portion TermLoanCurrentPortion	27500000	usd
CY2021Q1	us-gaap	Asset Retirement Obligation AssetRetirementObligation	13330000	usd
CY2022	us-gaap	Asset Retirement Obligation Liabilities Incurred AssetRetirementObligationLiabilitiesIncurred	86000	usd
CY2022	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	3000	usd
CY2022	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	146000	usd
CY2022	us-gaap	Asset Retirement Obligation Foreign Currency Translation Gain Loss AssetRetirementObligationForeignCurrencyTranslationGainLoss	-16000	usd
CY2022Q1	us-gaap	Asset Retirement Obligation AssetRetirementObligation	13543000	usd
CY2023	us-gaap	Asset Retirement Obligation Liabilities Incurred AssetRetirementObligationLiabilitiesIncurred	86000	usd
CY2023	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	625000	usd
CY2023	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	104000	usd
CY2023	us-gaap	Asset Retirement Obligation Foreign Currency Translation Gain Loss AssetRetirementObligationForeignCurrencyTranslationGainLoss	23000	usd
CY2023Q1	us-gaap	Asset Retirement Obligation AssetRetirementObligation	13131000	usd
CY2023Q1	ste	Term Loan Current Portion TermLoanCurrentPortion	27500000	usd
CY2023Q1	ste	Delayed Draw Term Loan Current Portion DelayedDrawTermLoanCurrentPortion	32500000	usd
CY2022Q1	ste	Delayed Draw Term Loan Current Portion DelayedDrawTermLoanCurrentPortion	24375000	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	60000000	usd
CY2022Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	142875000	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	301672000	usd
CY2022Q1	us-gaap	Line Of Credit LineOfCredit	58908000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	21444000	usd
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	25278000	usd
CY2023Q1	ste	Term Loan Long Term Portion TermLoanLongTermPortion	45000000	usd
CY2022Q1	ste	Term Loan Long Term Portion TermLoanLongTermPortion	177500000	usd
CY2023Q1	ste	Delayed Draw Term Loan Long Term Portion DelayedDrawTermLoanLongTermPortion	593125000	usd
CY2022Q1	ste	Delayed Draw Term Loan Long Term Portion DelayedDrawTermLoanLongTermPortion	625625000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	3018655000	usd
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	2945481000	usd
CY2023Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	3078655000	usd
CY2022Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	3088356000	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	301672000	usd
CY2022Q2	ste	Delayed Draw Term Loan Long Term Portion DelayedDrawTermLoanLongTermPortion	650000000	usd
CY2021Q2	ste	Business Acquisition Shares Received Per Ordinary Share BusinessAcquisitionSharesReceivedPerOrdinaryShare	0.33787	shares
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q2	ste	Debt Instrument Convertible Units Of Property Reference DebtInstrumentConvertibleUnitsOfPropertyReference	25.0843
CY2021Q2	ste	Debt Instrument Convertible Parent Shares DebtInstrumentConvertibleParentShares	8.4752	shares
CY2021Q2	ste	Debt Instrument Convertible Cash Per One Thousand Dollars Ratio DebtInstrumentConvertibleCashPerOneThousandDollarsRatio	424.68
CY2021Q2	ste	Debt Instrument Convertible Increase In Conversion Rate Shares DebtInstrumentConvertibleIncreaseInConversionRateShares	0.9931	shares
CY2021Q2	ste	Debt Instrument Convertible Stock Price DebtInstrumentConvertibleStockPrice	81.3520
CY2022	ste	Consideration Related To Equity Component Of Convertible Debt ConsiderationRelatedToEquityComponentOfConvertibleDebt	175555000	usd

CY2023

dei

Entity Central Index Key

EntityCentralIndexKey

0001757898

CY2023

dei

Document Period End Date

DocumentPeriodEndDate

2023-03-31

CY2023

dei

Current Fiscal Year End Date

CurrentFiscalYearEndDate

--03-31

CY2023

dei

Amendment Flag

AmendmentFlag

false

CY2023

dei

Document Fiscal Year Focus

DocumentFiscalYearFocus

2023

CY2023

dei

Document Fiscal Period Focus

DocumentFiscalPeriodFocus

FY

CY2023Q2

dei

Entity Common Stock Shares Outstanding

EntityCommonStockSharesOutstanding

98650238

shares

CY2022Q3

dei

Entity Public Float

EntityPublicFloat

16561000000

usd

CY2022Q1

us-gaap

Indefinite Lived Intangible Assets Excluding Goodwill

IndefiniteLivedIntangibleAssetsExcludingGoodwill

14250000

usd

CY2023

dei

Document Type

DocumentType

10-K

CY2023

dei

Document Annual Report

DocumentAnnualReport

true

CY2023

dei

Document Period End Date

DocumentPeriodEndDate

2023-03-31

CY2023

dei

Current Fiscal Year End Date

CurrentFiscalYearEndDate

--03-31

CY2023

dei

Document Transition Report

DocumentTransitionReport

false

CY2023

dei

Entity File Number

EntityFileNumber

001-38848

CY2023

dei

Entity Registrant Name

EntityRegistrantName

STERIS plc

CY2023

dei

Entity Incorporation State Country Code

EntityIncorporationStateCountryCode

L2

CY2023

dei

Entity Tax Identification Number

EntityTaxIdentificationNumber

98-1455064

CY2023

dei

Entity Address Address Line1

EntityAddressAddressLine1

70 Sir John Rogerson's Quay,

CY2023

dei

Entity Address City Or Town

EntityAddressCityOrTown

Dublin 2,

CY2023

dei

Entity Address Country

EntityAddressCountry

IE

CY2023

dei

Entity Address Postal Zip Code

EntityAddressPostalZipCode

D02 R296

CY2023

dei

Country Region

CountryRegion

353

CY2023

dei

City Area Code

CityAreaCode

1

CY2023

dei

Local Phone Number

LocalPhoneNumber

232 2000

CY2023

dei

Entity Well Known Seasoned Issuer

EntityWellKnownSeasonedIssuer

Yes

CY2023

dei

Entity Voluntary Filers

EntityVoluntaryFilers

No

CY2023

dei

Entity Current Reporting Status

EntityCurrentReportingStatus

Yes

CY2023

dei

Entity Interactive Data Current

EntityInteractiveDataCurrent

Yes

CY2023

dei

Entity Filer Category

EntityFilerCategory

Large Accelerated Filer

CY2023

dei

Entity Small Business

EntitySmallBusiness

false

CY2023

dei

Entity Emerging Growth Company

EntityEmergingGrowthCompany

false

CY2023

dei

Icfr Auditor Attestation Flag

IcfrAuditorAttestationFlag

true

CY2023

dei

Entity Shell Company

EntityShellCompany

false

CY2022Q3

dei

Entity Public Float

EntityPublicFloat

16561000000

usd

CY2023Q2

dei

Entity Common Stock Shares Outstanding

EntityCommonStockSharesOutstanding

98650238

shares

CY2023

dei

Auditor Firm

AuditorFirmId

42

CY2023

dei

Auditor Name

AuditorName

Ernst & Young LLP

CY2023

dei

Auditor Location

AuditorLocation

Cleveland, Ohio

CY2023Q1

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

208357000

usd

CY2022Q1

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

348320000

usd

CY2023Q1

us-gaap

Allowance For Doubtful Accounts Receivable Current

AllowanceForDoubtfulAccountsReceivableCurrent

23427000

usd

CY2022Q1

us-gaap

Allowance For Doubtful Accounts Receivable Current

AllowanceForDoubtfulAccountsReceivableCurrent

24371000

usd

CY2023Q1

us-gaap

Accounts Receivable Net Current

AccountsReceivableNetCurrent

928315000

usd

CY2022Q1

us-gaap

Accounts Receivable Net Current

AccountsReceivableNetCurrent

799041000

usd

CY2023Q1

us-gaap

Inventory Net

InventoryNet

695493000

usd

CY2022Q1

us-gaap

Inventory Net

InventoryNet

574999000

usd

CY2023Q1

us-gaap

Other Prepaid Expense Current

OtherPrepaidExpenseCurrent

179277000

usd

CY2022Q1

us-gaap

Other Prepaid Expense Current

OtherPrepaidExpenseCurrent

156637000

usd

CY2023Q1

us-gaap

Assets Current

AssetsCurrent

2011442000

usd

CY2022Q1

us-gaap

Assets Current

AssetsCurrent

1878997000

usd

CY2023Q1

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

1705512000

usd

CY2022Q1

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

1552576000

usd

CY2023Q1

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

191741000

usd

CY2022Q1

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

188480000

usd

CY2023Q1

us-gaap

Goodwill

3879219000

usd

CY2022Q1

us-gaap

Goodwill

4404343000

usd

CY2023Q1

us-gaap

Intangible Assets Net Excluding Goodwill

IntangibleAssetsNetExcludingGoodwill

2955780000

usd

CY2022Q1

us-gaap

Intangible Assets Net Excluding Goodwill

IntangibleAssetsNetExcludingGoodwill

3328537000

usd

CY2023Q1

us-gaap

Other Assets Noncurrent

OtherAssetsNoncurrent

78145000

usd

CY2022Q1

us-gaap

Other Assets Noncurrent

OtherAssetsNoncurrent

70661000

usd

CY2023Q1

us-gaap

Assets

10821839000

usd

CY2022Q1

us-gaap

Assets

11423594000

usd

CY2023Q1

us-gaap

Accounts Payable Current

AccountsPayableCurrent

279620000

usd

CY2022Q1

us-gaap

Accounts Payable Current

AccountsPayableCurrent

225737000

usd

CY2023Q1

us-gaap

Accrued Income Taxes Current

AccruedIncomeTaxesCurrent

43804000

usd

CY2022Q1

us-gaap

Accrued Income Taxes Current

AccruedIncomeTaxesCurrent

26873000

usd

CY2023Q1

us-gaap

Employee Related Liabilities Current

EmployeeRelatedLiabilitiesCurrent

125642000

usd

CY2022Q1

us-gaap

Employee Related Liabilities Current

EmployeeRelatedLiabilitiesCurrent

183721000

usd

CY2023Q1

us-gaap

Operating Lease Liability Current

OperatingLeaseLiabilityCurrent

34961000

usd

CY2022Q1

us-gaap

Operating Lease Liability Current

OperatingLeaseLiabilityCurrent

36472000

usd

CY2023Q1

us-gaap

Short Term Borrowings

ShortTermBorrowings

60000000

usd

CY2022Q1

us-gaap

Short Term Borrowings

ShortTermBorrowings

142875000

usd

CY2023Q1

us-gaap

Accrued Liabilities Current

AccruedLiabilitiesCurrent

317817000

usd

CY2022Q1

us-gaap

Accrued Liabilities Current

AccruedLiabilitiesCurrent

306544000

usd

CY2023Q1

us-gaap

Liabilities Current

LiabilitiesCurrent

861844000

usd

CY2022Q1

us-gaap

Liabilities Current

LiabilitiesCurrent

922222000

usd

CY2023Q1

us-gaap

Long Term Debt Noncurrent

LongTermDebtNoncurrent

3018655000

usd

CY2022Q1

us-gaap

Long Term Debt Noncurrent

LongTermDebtNoncurrent

2945481000

usd

CY2023Q1

us-gaap

Deferred Income Taxes And Other Tax Liabilities Noncurrent

DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent

617538000

usd

CY2022Q1

us-gaap

Deferred Income Taxes And Other Tax Liabilities Noncurrent

DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent

780619000

usd

CY2023Q1

us-gaap

Operating Lease Liability Noncurrent

OperatingLeaseLiabilityNoncurrent

160493000

usd

CY2022Q1

us-gaap

Operating Lease Liability Noncurrent

OperatingLeaseLiabilityNoncurrent

155056000

usd

CY2023Q1

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

76137000

usd

CY2022Q1

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

75579000

usd

CY2023Q1

us-gaap

Liabilities

4734667000

usd

CY2022Q1

us-gaap

Liabilities

4878957000

usd

CY2023Q1

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

usd

CY2022Q1

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

usd

CY2023Q1

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.001

CY2023Q1

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

500000000

shares

CY2023Q1

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

98629000

shares

CY2023Q1

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

98629000

shares

CY2022Q1

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

100067000

shares

CY2022Q1

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

100067000

shares

CY2023Q1

us-gaap

Common Stock Value

CommonStockValue

4486375000

usd

CY2022Q1

us-gaap

Common Stock Value

CommonStockValue

4742920000

usd

CY2023Q1

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

1911533000

usd

CY2022Q1

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

1999244000

usd

CY2023Q1

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-320710000

usd

CY2022Q1

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-209808000

usd

CY2023Q1

us-gaap

Stockholders Equity

StockholdersEquity

6077198000

usd

CY2022Q1

us-gaap

Stockholders Equity

StockholdersEquity

6532356000

usd

CY2023Q1

us-gaap

Minority Interest

MinorityInterest

9974000

usd

CY2022Q1

us-gaap

Minority Interest

MinorityInterest

12281000

usd

CY2023Q1

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

6087172000

usd

CY2021Q1

ste

Deferred Consideration

DeferredConsideration

1194000

usd

CY2022Q1

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

6544637000

usd

CY2023Q1

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

10821839000

usd

CY2022Q1

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

11423594000

usd

CY2023

us-gaap

Revenues

4957839000

usd

CY2022

us-gaap

Revenues

4585064000

usd

CY2021

us-gaap

Revenues

3107519000

usd

CY2023

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

2798147000

usd

CY2022

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

2568702000

usd

CY2021

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

1764419000

usd

CY2023

us-gaap

Gross Profit

GrossProfit

2159692000

usd

CY2022

us-gaap

Gross Profit

GrossProfit

2016362000

usd

CY2021

us-gaap

Gross Profit

GrossProfit

1343100000

usd

CY2023

us-gaap

Selling General And Administrative Expense

SellingGeneralAndAdministrativeExpense

1298876000

usd

CY2022

us-gaap

Selling General And Administrative Expense

SellingGeneralAndAdministrativeExpense

1502752000

usd

CY2021

us-gaap

Selling General And Administrative Expense

SellingGeneralAndAdministrativeExpense

731320000

usd

CY2023

us-gaap

Goodwill Impairment Loss

GoodwillImpairmentLoss

490565000

usd

CY2022

us-gaap

Goodwill Impairment Loss

GoodwillImpairmentLoss

0

usd

CY2021

us-gaap

Goodwill Impairment Loss

GoodwillImpairmentLoss

0

usd

CY2023

us-gaap

Research And Development Expense

ResearchAndDevelopmentExpense

101581000

usd

CY2022

us-gaap

Research And Development Expense

ResearchAndDevelopmentExpense

87944000

usd

CY2021

us-gaap

Research And Development Expense

ResearchAndDevelopmentExpense

66326000

usd

CY2023

us-gaap

Restructuring Costs

RestructuringCosts

485000

usd

CY2022

us-gaap

Restructuring Costs

RestructuringCosts

48000

usd

CY2021

us-gaap

Restructuring Costs

RestructuringCosts

-2914000

usd

CY2023

us-gaap

Operating Expenses

OperatingExpenses

1891507000

usd

CY2022

us-gaap

Operating Expenses

OperatingExpenses

1590744000

usd

CY2021

us-gaap

Operating Expenses

OperatingExpenses

794732000

usd

CY2023

us-gaap

Operating Income Loss

OperatingIncomeLoss

268185000

usd

CY2022

us-gaap

Operating Income Loss

OperatingIncomeLoss

425618000

usd

CY2021

us-gaap

Operating Income Loss

OperatingIncomeLoss

548368000

usd

CY2023

us-gaap

Interest Expense

InterestExpense

107989000

usd

CY2022

us-gaap

Interest Expense

InterestExpense

89593000

usd

CY2021

us-gaap

Interest Expense

InterestExpense

37180000

usd

CY2023

ste

Fair Value Adjustment Related To Convertible Debt Liability

FairValueAdjustmentRelatedToConvertibleDebtLiability

0

usd

CY2022

ste

Fair Value Adjustment Related To Convertible Debt Liability

FairValueAdjustmentRelatedToConvertibleDebtLiability

27806000

usd

CY2021

ste

Fair Value Adjustment Related To Convertible Debt Liability

FairValueAdjustmentRelatedToConvertibleDebtLiability

0

usd

CY2023

us-gaap

Other Nonoperating Income Expense

OtherNonoperatingIncomeExpense

-2848000

usd

CY2022

us-gaap

Other Nonoperating Income Expense

OtherNonoperatingIncomeExpense

6284000

usd

CY2021

us-gaap

Other Nonoperating Income Expense

OtherNonoperatingIncomeExpense

6345000

usd

CY2023

us-gaap

Nonoperating Income Expense

NonoperatingIncomeExpense

-110837000

usd

CY2022

us-gaap

Nonoperating Income Expense

NonoperatingIncomeExpense

-111115000

usd

CY2021

us-gaap

Nonoperating Income Expense

NonoperatingIncomeExpense

-30835000

usd

CY2023

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

157348000

usd

CY2022

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

314503000

usd

CY2021

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

517533000

usd

CY2023

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

51535000

usd

CY2022

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

71633000

usd

CY2021

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

120663000

usd

CY2023

us-gaap

Profit Loss

ProfitLoss

105813000

usd

CY2022

us-gaap

Profit Loss

ProfitLoss

242870000

usd

CY2021

us-gaap

Profit Loss

ProfitLoss

396870000

usd

CY2023

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

-1217000

usd

CY2022

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

-1018000

usd

CY2021

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

-530000

usd

CY2023

us-gaap

Net Income Loss

NetIncomeLoss

107030000

usd

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

243888000

usd

CY2021

us-gaap

Net Income Loss

NetIncomeLoss

397400000

usd

CY2023

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

1.07

CY2022

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

2.50

CY2021

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

4.66

CY2023

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

1.07

CY2022

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

2.48

CY2021

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

4.63

CY2023

us-gaap

Common Stock Dividends Per Share Declared

CommonStockDividendsPerShareDeclared

1.84

CY2022

us-gaap

Common Stock Dividends Per Share Declared

CommonStockDividendsPerShareDeclared

1.69

CY2021

us-gaap

Common Stock Dividends Per Share Declared

CommonStockDividendsPerShareDeclared

1.57

CY2023

us-gaap

Profit Loss

ProfitLoss

105813000

usd

CY2022

us-gaap

Profit Loss

ProfitLoss

242870000

usd

CY2021

us-gaap

Profit Loss

ProfitLoss

396870000

usd

CY2023

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

-1217000

usd

CY2022

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

-1018000

usd

CY2021

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

-530000

usd

CY2023

us-gaap

Net Income Loss

NetIncomeLoss

107030000

usd

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

243888000

usd

CY2021

us-gaap

Net Income Loss

NetIncomeLoss

397400000

usd

CY2023

us-gaap

Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax

OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax

521000

usd

CY2022

us-gaap

Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax

OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax

507000

usd

CY2021

us-gaap

Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax

OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax

667000

usd

CY2023

us-gaap

Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax

OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax

-1264000

usd

CY2022

us-gaap

Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax

OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax

6795000

usd

CY2021

us-gaap

Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax

OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax

1294000

usd

CY2023

us-gaap

Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax

OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax

-109638000

usd

CY2022

us-gaap

Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax

OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax

-155360000

usd

CY2021

us-gaap

Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax

OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax

172926000

usd

CY2023

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

-110902000

usd

CY2022

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

-148565000

usd

CY2021

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

174220000

usd

CY2023

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

-3872000

usd

CY2022

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

95323000

usd

CY2021

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

571620000

usd

CY2023

us-gaap

Profit Loss

ProfitLoss

105813000

usd

CY2022

us-gaap

Profit Loss

ProfitLoss

242870000

usd

CY2021

us-gaap

Profit Loss

ProfitLoss

396870000

usd

CY2023

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

552897000

usd

CY2022

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

553104000

usd

CY2021

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

219237000

usd

CY2023

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

-185913000

usd

CY2022

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

-106620000

usd

CY2021

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

4240000

usd

CY2023

us-gaap

Share Based Compensation

ShareBasedCompensation

38951000

usd

CY2022

us-gaap

Share Based Compensation

ShareBasedCompensation

57660000

usd

CY2021

us-gaap

Share Based Compensation

ShareBasedCompensation

25966000

usd

CY2023

us-gaap

Gain Loss On Sale Of Property Plant Equipment

GainLossOnSaleOfPropertyPlantEquipment

-22193000

usd

CY2022

us-gaap

Gain Loss On Sale Of Property Plant Equipment

GainLossOnSaleOfPropertyPlantEquipment

-15117000

usd

CY2021

us-gaap

Gain Loss On Sale Of Property Plant Equipment

GainLossOnSaleOfPropertyPlantEquipment

1982000

usd

CY2023

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

67000

usd

CY2022

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

874000

usd

CY2021

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

-2030000

usd

CY2023

ste

Fair Value Adjustment Related To Convertible Debt Liability

FairValueAdjustmentRelatedToConvertibleDebtLiability

0

usd

CY2022

ste

Fair Value Adjustment Related To Convertible Debt Liability

FairValueAdjustmentRelatedToConvertibleDebtLiability

27806000

usd

CY2021

ste

Fair Value Adjustment Related To Convertible Debt Liability

FairValueAdjustmentRelatedToConvertibleDebtLiability

0

usd

CY2023

ste

Amortization Of Inventory Fair Value Adjustments

AmortizationOfInventoryFairValueAdjustments

7363000

usd

CY2022

ste

Amortization Of Inventory Fair Value Adjustments

AmortizationOfInventoryFairValueAdjustments

66663000

usd

CY2021

ste

Amortization Of Inventory Fair Value Adjustments

AmortizationOfInventoryFairValueAdjustments

0

usd

CY2023

us-gaap

Goodwill Impairment Loss

GoodwillImpairmentLoss

490565000

usd

CY2022

us-gaap

Goodwill Impairment Loss

GoodwillImpairmentLoss

0

usd

CY2021

us-gaap

Goodwill Impairment Loss

GoodwillImpairmentLoss

0

usd

CY2023

us-gaap

Other Noncash Income Expense

OtherNoncashIncomeExpense

24832000

usd

CY2022

us-gaap

Other Noncash Income Expense

OtherNoncashIncomeExpense

21639000

usd

CY2021

us-gaap

Other Noncash Income Expense

OtherNoncashIncomeExpense

-24273000

usd

CY2023

us-gaap

Increase Decrease In Accounts Receivable

IncreaseDecreaseInAccountsReceivable

133304000

usd

CY2022

us-gaap

Increase Decrease In Accounts Receivable

IncreaseDecreaseInAccountsReceivable

51969000

usd

CY2021

us-gaap

Increase Decrease In Accounts Receivable

IncreaseDecreaseInAccountsReceivable

-12076000

usd

CY2023

us-gaap

Increase Decrease In Inventories

IncreaseDecreaseInInventories

123921000

usd

CY2022

us-gaap

Increase Decrease In Inventories

IncreaseDecreaseInInventories

102922000

usd

CY2021

us-gaap

Increase Decrease In Inventories

IncreaseDecreaseInInventories

-3769000

usd

CY2023

us-gaap

Increase Decrease In Prepaid Deferred Expense And Other Assets

IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

24086000

usd

CY2022

us-gaap

Increase Decrease In Prepaid Deferred Expense And Other Assets

IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

-7126000

usd

CY2021

us-gaap

Increase Decrease In Prepaid Deferred Expense And Other Assets

IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

-458000

usd

CY2023

us-gaap

Increase Decrease In Accounts Payable

IncreaseDecreaseInAccountsPayable

53342000

usd

CY2022

us-gaap

Increase Decrease In Accounts Payable

IncreaseDecreaseInAccountsPayable

14887000

usd

CY2021

us-gaap

Increase Decrease In Accounts Payable

IncreaseDecreaseInAccountsPayable

-7213000

usd

CY2023

us-gaap

Increase Decrease In Accrued Liabilities

IncreaseDecreaseInAccruedLiabilities

-22054000

usd

CY2022

us-gaap

Increase Decrease In Accrued Liabilities

IncreaseDecreaseInAccruedLiabilities

-16398000

usd

CY2021

us-gaap

Increase Decrease In Accrued Liabilities

IncreaseDecreaseInAccruedLiabilities

9916000

usd

CY2023

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

756947000

usd

CY2022

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

684811000

usd

CY2021

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

689640000

usd

CY2023

us-gaap

Payments To Acquire Property Plant And Equipment

PaymentsToAcquirePropertyPlantAndEquipment

361969000

usd

CY2022

us-gaap

Payments To Acquire Property Plant And Equipment

PaymentsToAcquirePropertyPlantAndEquipment

287563000

usd

CY2021

us-gaap

Payments To Acquire Property Plant And Equipment

PaymentsToAcquirePropertyPlantAndEquipment

239262000

usd

CY2023

us-gaap

Proceeds From Sale Of Property Plant And Equipment

ProceedsFromSaleOfPropertyPlantAndEquipment

14587000

usd

CY2022

us-gaap

Proceeds From Sale Of Property Plant And Equipment

ProceedsFromSaleOfPropertyPlantAndEquipment

1741000

usd

CY2021

us-gaap

Proceeds From Sale Of Property Plant And Equipment

ProceedsFromSaleOfPropertyPlantAndEquipment

569000

usd

CY2023

us-gaap

Proceeds From Divestiture Of Businesses

ProceedsFromDivestitureOfBusinesses

6624000

usd

CY2022

us-gaap

Proceeds From Divestiture Of Businesses

ProceedsFromDivestitureOfBusinesses

169712000

usd

CY2021

us-gaap

Proceeds From Divestiture Of Businesses

ProceedsFromDivestitureOfBusinesses

518000

usd

CY2023

us-gaap

Payments To Acquire Investments

PaymentsToAcquireInvestments

0

usd

CY2022

us-gaap

Payments To Acquire Investments

PaymentsToAcquireInvestments

0

usd

CY2021

us-gaap

Payments To Acquire Investments

PaymentsToAcquireInvestments

4400000

usd

CY2023

us-gaap

Payments To Acquire Businesses Net Of Cash Acquired

PaymentsToAcquireBusinessesNetOfCashAcquired

42572000

usd

CY2022

us-gaap

Payments To Acquire Businesses Net Of Cash Acquired

PaymentsToAcquireBusinessesNetOfCashAcquired

550449000

usd

CY2021

us-gaap

Payments To Acquire Businesses Net Of Cash Acquired

PaymentsToAcquireBusinessesNetOfCashAcquired

909192000

usd

CY2023

us-gaap

Payments For Proceeds From Other Investing Activities

PaymentsForProceedsFromOtherInvestingActivities

0

usd

CY2022

us-gaap

Payments For Proceeds From Other Investing Activities

PaymentsForProceedsFromOtherInvestingActivities

0

usd

CY2021

us-gaap

Payments For Proceeds From Other Investing Activities

PaymentsForProceedsFromOtherInvestingActivities

2392000

usd

CY2023

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-383330000

usd

CY2022

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-666559000

usd

CY2021

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-1154159000

usd

CY2023

us-gaap

Proceeds From Issuance Of Senior Long Term Debt

ProceedsFromIssuanceOfSeniorLongTermDebt

0

usd

CY2022

us-gaap

Proceeds From Issuance Of Senior Long Term Debt

ProceedsFromIssuanceOfSeniorLongTermDebt

1350000000

usd

CY2021

us-gaap

Proceeds From Issuance Of Senior Long Term Debt

ProceedsFromIssuanceOfSeniorLongTermDebt

0

usd

CY2023

us-gaap

Proceeds From Issuance Of Debt

ProceedsFromIssuanceOfDebt

0

usd

CY2022

us-gaap

Proceeds From Issuance Of Debt

ProceedsFromIssuanceOfDebt

650000000

usd

CY2021

us-gaap

Proceeds From Issuance Of Debt

ProceedsFromIssuanceOfDebt

550000000

usd

CY2023

ste

Repayments Of Term Loans

RepaymentsOfTermLoans

156875000

usd

CY2022

ste

Repayments Of Term Loans

RepaymentsOfTermLoans

345000000

usd

CY2021

ste

Repayments Of Term Loans

RepaymentsOfTermLoans

0

usd

CY2023

us-gaap

Repayments Of Debt And Capital Lease Obligations

RepaymentsOfDebtAndCapitalLeaseObligations

91000000

usd

CY2022

us-gaap

Repayments Of Debt And Capital Lease Obligations

RepaymentsOfDebtAndCapitalLeaseObligations

721284000

usd

CY2021

us-gaap

Repayments Of Debt And Capital Lease Obligations

RepaymentsOfDebtAndCapitalLeaseObligations

35000000

usd

CY2023

us-gaap

Repayments Of Convertible Debt

RepaymentsOfConvertibleDebt

0

usd

CY2022

us-gaap

Repayments Of Convertible Debt

RepaymentsOfConvertibleDebt

371361000

usd

CY2021

us-gaap

Repayments Of Convertible Debt

RepaymentsOfConvertibleDebt

0

usd

CY2023

us-gaap

Proceeds From Repayments Of Lines Of Credit

ProceedsFromRepaymentsOfLinesOfCredit

241657000

usd

CY2022

us-gaap

Proceeds From Repayments Of Lines Of Credit

ProceedsFromRepaymentsOfLinesOfCredit

-190174000

usd

CY2021

us-gaap

Proceeds From Repayments Of Lines Of Credit

ProceedsFromRepaymentsOfLinesOfCredit

-30461000

usd

CY2023

us-gaap

Payments Of Financing Costs

PaymentsOfFinancingCosts

0

usd

CY2022

us-gaap

Payments Of Financing Costs

PaymentsOfFinancingCosts

17472000

usd

CY2021

us-gaap

Payments Of Financing Costs

PaymentsOfFinancingCosts

12846000

usd

CY2023

us-gaap

Payments Of Merger Related Costs Financing Activities

PaymentsOfMergerRelatedCostsFinancingActivities

1471000

usd

CY2022

us-gaap

Payments Of Merger Related Costs Financing Activities

PaymentsOfMergerRelatedCostsFinancingActivities

32679000

usd

CY2021

us-gaap

Payments Of Merger Related Costs Financing Activities

PaymentsOfMergerRelatedCostsFinancingActivities

2395000

usd

CY2023

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

308565000

usd

CY2022

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

55777000

usd

CY2021

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

14646000

usd

CY2023

us-gaap

Payments Of Dividends Common Stock

PaymentsOfDividendsCommonStock

183498000

usd

CY2022

us-gaap

Payments Of Dividends Common Stock

PaymentsOfDividendsCommonStock

163169000

usd

CY2021

us-gaap

Payments Of Dividends Common Stock

PaymentsOfDividendsCommonStock

133837000

usd

CY2023

us-gaap

Payments To Minority Shareholders

PaymentsToMinorityShareholders

794000

usd

CY2022

us-gaap

Payments To Minority Shareholders

PaymentsToMinorityShareholders

997000

usd

CY2021

us-gaap

Payments To Minority Shareholders

PaymentsToMinorityShareholders

4179000

usd

CY2023

us-gaap

Proceeds From Minority Shareholders

ProceedsFromMinorityShareholders

0

usd

CY2022

us-gaap

Proceeds From Minority Shareholders

ProceedsFromMinorityShareholders

3672000

usd

CY2021

us-gaap

Proceeds From Minority Shareholders

ProceedsFromMinorityShareholders

2258000

usd

CY2023

us-gaap

Proceeds From Payments For Other Financing Activities

ProceedsFromPaymentsForOtherFinancingActivities

1828000

usd

CY2022

us-gaap

Proceeds From Payments For Other Financing Activities

ProceedsFromPaymentsForOtherFinancingActivities

10071000

usd

CY2021

us-gaap

Proceeds From Payments For Other Financing Activities

ProceedsFromPaymentsForOtherFinancingActivities

26726000

usd

CY2023

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-498718000

usd

CY2022

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

115830000

usd

CY2021

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

345620000

usd

CY2023

us-gaap

Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

-14862000

usd

CY2022

us-gaap

Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

-6293000

usd

CY2021

us-gaap

Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

19849000

usd

CY2023

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

-139963000

usd

CY2022

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

127789000

usd

CY2021

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

-99050000

usd

CY2022Q1

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

348320000

usd

CY2021Q1

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

220531000

usd

CY2020Q1

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

319581000

usd

CY2023Q1

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

208357000

usd

CY2022Q1

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

348320000

usd

CY2021Q1

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

220531000

usd

CY2021

us-gaap

Profit Loss

ProfitLoss

396870000

usd

CY2021

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest

-174220000

usd

CY2021

us-gaap

Stock Repurchased And Retired During Period Value

StockRepurchasedAndRetiredDuringPeriodValue

14646000

usd

CY2021

us-gaap

Stock Issued During Period Value Employee Stock Purchase Plan

StockIssuedDuringPeriodValueEmployeeStockPurchasePlan

52491000

usd

CY2021

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

1.57

CY2021

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

133837000

usd

CY2021

us-gaap

Minority Interest Decrease From Distributions To Noncontrolling Interest Holders

MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders

4179000

usd

CY2021

ste

Noncontrolling Interest Increase From Contributions To Noncontrolling Interest Holders

NoncontrollingInterestIncreaseFromContributionsToNoncontrollingInterestHolders

2258000

usd

CY2021

ste

Increase Decrease In Noncontrolling Interests Other

IncreaseDecreaseInNoncontrollingInterestsOther

-81000

usd

CY2021Q1

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

3891468000

usd

CY2022

us-gaap

Profit Loss

ProfitLoss

242870000

usd

CY2022

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest

148565000

usd

CY2022

us-gaap

Stock Repurchased And Retired During Period Value

StockRepurchasedAndRetiredDuringPeriodValue

55777000

usd

CY2022

us-gaap

Stock Issued During Period Value Employee Stock Purchase Plan

StockIssuedDuringPeriodValueEmployeeStockPurchasePlan

67499000

usd

CY2022

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

1.69

CY2022

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

163169000

usd

CY2022

us-gaap

Stock Issued During Period Value Acquisitions

StockIssuedDuringPeriodValueAcquisitions

2689317000

usd

CY2022

ste

Consideration Related To Equity Component Of Cantel Convertible Debt

ConsiderationRelatedToEquityComponentOfCantelConvertibleDebt

175555000

usd

CY2022

ste

Consideration Related To Cantel Equity Compensation Programs

ConsiderationRelatedToCantelEquityCompensationPrograms

18173000

usd

CY2022

ste

Reclassification To Cantel Convertible Debt Premium Liability

ReclassificationToCantelConvertibleDebtPremiumLiability

175555000

usd

CY2022

us-gaap

Minority Interest Decrease From Distributions To Noncontrolling Interest Holders

MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders

997000

usd

CY2022

ste

Noncontrolling Interest Increase From Contributions To Noncontrolling Interest Holders

NoncontrollingInterestIncreaseFromContributionsToNoncontrollingInterestHolders

3672000

usd

CY2022

ste

Increase Decrease In Noncontrolling Interests Other

IncreaseDecreaseInNoncontrollingInterestsOther

-146000

usd

CY2022Q1

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

6544637000

usd

CY2023

us-gaap

Profit Loss

ProfitLoss

105813000

usd

CY2023

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest

110902000

usd

CY2023

us-gaap

Stock Repurchased And Retired During Period Value

StockRepurchasedAndRetiredDuringPeriodValue

308565000

usd

CY2023

us-gaap

Stock Issued During Period Value Employee Stock Purchase Plan

StockIssuedDuringPeriodValueEmployeeStockPurchasePlan

40777000

usd

CY2023

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

1.84

CY2023

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

183498000

usd

CY2023

us-gaap

Minority Interest Decrease From Distributions To Noncontrolling Interest Holders

MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders

794000

usd

CY2023

ste

Increase Decrease In Noncontrolling Interests Other

IncreaseDecreaseInNoncontrollingInterestsOther

296000

usd

CY2023Q1

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

6087172000

usd

CY2023

us-gaap

Nature Of Operations

NatureOfOperations

<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nature of Operations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare, life sciences and dental products and services. We offer our Customers a unique mix of innovative consumable products, such as detergents, endoscopy accessories, barrier products, and other products and services, including: equipment installation and maintenance, microbial reduction of medical devices, dental instruments and tools, instrument and scope repair, laboratory testing services, outsourced reprocessing, and capital equipment products, such as sterilizers and surgical tables, automated endoscope reprocessors, and connectivity solutions such as operating room (“OR”) integrati</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate and report in four reportable business segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. We describe our business segments in Note 11 titled, "Business Segment Information."</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year ends on March 31. References in this Annual Report to a particular "year," "fiscal," "fiscal year," or "year-end" mean our fiscal year. The significant accounting policies applied in preparing the accompanying consolidated financial statements of the Company are summarized below.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the consolidation method to report our investment in our subsidiaries. Therefore, the accompanying consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. We eliminate intercompany accounts and transactions when we consolidate these accounts. Investments in equity of unconsolidated affiliates, over which the Company has significant influence, but not control, over the financial and operating polices, are accounted for primarily using the equity method. These investments are immaterial to the Company's consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We make certain estimates and assumptions when preparing financial statements according to U.S. GAAP that affect the reported amounts of assets and liabilities at the financial statement dates and the reported amounts of revenues and expenses during the periods presented. These estimates and assumptions involve judgments with respect to many factors that are difficult to predict and are beyond our control. Actual results could be materially different from these estimates. We revise the estimates and assumptions as new information becomes available.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents and Supplemental Cash Flow Information. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are all highly liquid investments with a maturity of three months or less when purchased. We invest our excess cash in short-term instruments including money market funds, money market deposit accounts, bank savings accounts, and time deposits with major banks and financial institutions. We select investments in accordance with the criteria established in our investment policy. Our investment policy specifies, among other things, maturity, credit quality and concentration restrictions with the objective of preserving capital and maintaining adequate liquidity.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information supplementing our Consolidated Statements of Cash Flows is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:55.263%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.692%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Years Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">108,470</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,696 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,257 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">254,661</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,382 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,646 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received during the year for income tax refunds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,315</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,605 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,631 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition and Associated Liabilities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when obligations under the terms of the contract are satisfied and control of the promised products or services have transferred to the Customer. Revenues are measured at the amount of consideration that we expect to be paid in exchange for the products or services. Product revenue is recognized when control passes to the Customer, which is generally based on contract or shipping terms. Service revenue is recognized when the Customer benefits from the service, which occurs either upon completion of the service or as it is provided to the Customer. Our Customers include end users as well as dealers and distributors who market and sell our products. Our revenue is not contingent upon resale by the dealer or distributor, and we have no further obligations related to bringing about resale. Our standard return and restocking fee policies are applied to sales of products. Shipping and handling costs charged to Customers are included in Product revenues. The associated expenses are treated as fulfillment costs and are included in Cost of revenues. Revenues are reported net of sales and value-added taxes collected from Customers.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have individual Customer contracts that offer discounted pricing. Dealers and distributors may be offered sales incentives in the form of rebates. We reduce revenue for discounts and estimated returns, rebates, and other similar allowances in the same period the related revenues are recorded. The reduction in revenue for these items is estimated based on historical experience and trend analysis to the extent that it is probable that a significant reversal of revenue will not occur. Estimated returns are recorded gross on the Consolidated Balance Sheets.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In transactions that contain multiple performance obligations, such as when products, maintenance services, and other services are combined, we recognize revenue as each product is delivered or service is provided to the Customer. We allocate the total arrangement consideration to each performance obligation based on its relative standalone selling price, which is the price for the product or service when it is sold separately.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment terms vary by the type and location of the Customer and the products or services offered. Generally, the time between when revenue is recognized and when payment is due is not significant. We do not evaluate whether the selling price contains a financing component for contracts that have a duration of less than one year.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not capitalize sales commissions as substantially all of our sales commission programs have an amortization period of one year or less.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain costs to fulfill a contract are capitalized and amortized over the term of the contract if they are recoverable, directly related to a contract and generate resources that we will use to fulfill the contract in the future. At March 31, 2023, assets related to costs to fulfill a contract were not material to our consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 11 titled, "Business Segment Information" for disaggregation of revenue.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Revenues</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenues consist of revenues generated from sales of consumables and capital equipment. These contracts are primarily based on a Customer’s purchase order and may include a Distributor, Dealer or Group Purchasing Organization ("GPO") agreement.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue for sales of product when control passes to the Customer, which generally occurs either when the products are shipped or when they are received by the Customer. Revenue related to capital equipment products is deferred until installation is complete if the capital equipment and installation are highly integrated and form a single performance obligation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Revenues</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our Healthcare and Life Sciences segments, service revenues include revenue generated from parts and labor associated with the maintenance, repair and installation of capital equipment. These contracts are primarily based on a Customer’s purchase order and may include a Distributor, Dealer, or GPO agreement. For maintenance, repair and installation of capital equipment, revenue is recognized upon completion of the service. Healthcare service revenues also include outsourced reprocessing services and instrument repairs. Contracts for outsourced reprocessing services are primarily based on an agreement with a Customer, ranging in length from several months to 15 years. Outsourced reprocessing services revenue is recognized ratably over the contract term using a time-based input measure, adjusted for volume and other performance metrics, to the extent that it is probable that a significant reversal of revenue will not occur. Contracts for instrument repairs are primarily based on a Customer’s purchase order, and the associated revenue is recognized upon completion of the repair. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer preventive maintenance and separately priced extended warranty agreements to our Customers, which require us to maintain and repair our products over the duration of the contract. Generally, these contract terms are cancellable without penalty and range from one to five years. Amounts received under these Customer contracts are initially recorded as a service liability and are recognized as service revenue ratably over the contract term using a time-based input measure. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our Applied Sterilization Technologies segment, service revenues include contract sterilization and laboratory services. Sales contracts for contract sterilization and laboratory services are primarily based on a Customer’s purchase order and associated Customer agreement and revenues are generally recognized upon completion of the service.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Liabilities</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments received from Customers are based on invoices or billing schedules as established in contracts with Customers. Deferred revenue is recorded when payment is received in advance of performance under the contract. Deferred revenue is recognized as revenue upon completion of the performance obligation, which generally occurs within one year. During fiscal 2023, we recognized revenue of $78,752 that was included in our contract liability balance at the beginning of the period. During fiscal 2022, we recognized revenue of $46,760 that was included in our contract liability balance at the beginning of the period.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 7 titled, "Additional Consolidated Balance Sheet Information" for deferred revenue balances.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Liabilities</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments received in advance of performance for cancellable preventive maintenance and separately priced extended warranty contracts are recorded as service liabilities. Service liabilities are recognized as revenue as performance is rendered under the contract. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 7 titled, "Additional Consolidated Balance Sheet Information" for service liability balances.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations reflect only the performance obligations related to agreements for which we have a firm commitment from a Customer to purchase, and exclude variable consideration related to unsatisfied performance obligations. With regard to products, these remaining performance obligations include capital equipment and consumable orders which have not shipped. With regard</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to service, these remaining performance obligations primarily include installation, certification, and outsourced reprocessing services. As of March 31, 2023, the transaction price allocated to remaining performance obligations was approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1,553,461</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We expect to recognize approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the transaction price within one year and approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> beyond one year. The remainder has yet to be scheduled for delivery.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Accounts receivable are presented at their face amount, less allowances for sales returns and uncollectible accounts. Accounts receivable consist of amounts billed and currently due from Customers and amounts earned but unbilled. We generally obtain and perfect security interest in products sold in the United States when we have a concern with the Customer's risk profile.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain an allowance for uncollectible accounts receivable for estimated losses in the collection of amounts owed by Customers. We estimate the allowance based on analyzing a number of factors, including amounts written off historically, Customer payment practices, and general economic conditions. We also analyze significant Customer accounts on a regular basis and record a specific allowance when we become aware of a specific Customer’s inability to pay. As a result, the related accounts receivable are reduced to an amount that we reasonably believe is collectible.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain an allowance for sales returns based upon known returns and estimated returns for both capital equipment and consumables. We estimate returns of capital equipment and consumables based upon recent historical experience.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> net. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of their cost and net realizable value determined by the first-in, first-out (“FIFO”) cost method. Inventory costs include material, labor, and overhead.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review inventory on an ongoing basis, considering factors such as deterioration, obsolescence, and other items. We record an allowance for estimated losses when the facts and circumstances indicate that particular inventories will not be usable. If future market conditions vary from those projected, and our estimates prove to be inaccurate, we may be required to write-down inventory values and record an adjustment to Cost of revenues.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant, and Equipment. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our property, plant, and equipment consists of land and land improvements, buildings and leasehold improvements, machinery and equipment, information systems, radioisotope (cobalt-60), and construction in progress. Property, plant, and equipment are presented at cost less accumulated depreciation and depletion. We capitalize additions and improvements. Repairs and maintenance are charged to expense as they are incurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land is not depreciated and construction in progress is not depreciated until placed in service. Depreciation of most assets is computed on the cost less the estimated salvage value by using the straight-line method over the estimated remaining useful lives. Depletion of radioisotope is computed using the annual decay factor of the material, which is similar to the sum-of-the-years-digits method.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally depreciate or deplete property, plant, and equipment over the useful lives presented in the following table:</span></div><div style="margin-bottom:6pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Useful Life<br/>(years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land improvements</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-40</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-50</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-20</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information Systems</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-20</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radioisotope (cobalt-60)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we sell, retire, or dispose of property, plant, and equipment, we remove the asset’s cost and accumulated depreciation from our Consolidated Balance Sheet. We recognize the net gain or loss on the sale or disposition in the Consolidated Statements of Income in the period when the transaction occurs.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize interest costs incurred during the construction of long-lived assets. We capitalized interest costs of $6,366 and $3,886 for the years ended March 31, 2023 and 2022, respectively. Total interest expense for the years ended March 31, 2023, 2022, and 2021 was $107,989, $89,593, and $37,180, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Identifiable Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our identifiable intangible assets include product technology rights, trademarks, licenses, non-compete agreements, and Customer and vendor relationships. We record these assets at cost, or when acquired as part of a business acquisition, at estimated fair value. Determining the fair value of identifiable intangible requires management’s judgment and often involves the use of significant estimates and assumptions, including assumptions with respect to forecasted revenue growth rates, forecasted profit margins, and Customer attrition rates, among other items. We generally amortize identifiable intangible assets over periods ranging from 5 to 20 years using the straight-line method. Our intangible assets also include indefinite lived assets including certain trademarks and tradenames that were acquired in connection with business combinations. These assets are tested at least annually for impairment. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Investments in marketable securities are stated at fair value and are included in Other assets on the Consolidated Balance Sheets. Changes in the fair value of these investments are recorded in the Interest income and miscellaneous expense (income) line of the Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Impairment Losses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Property, plant, equipment, and identifiable intangible assets are reviewed for impairment when indicators of impairment exist and circumstances indicate that the carrying value of such assets may not be recoverable. Impaired assets are recorded at the lower of carrying value or estimated fair value. We monitor for such indicators on an ongoing basis and if an impairment exists, we record the loss in the Consolidated Statements of Income during that period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Retirement Obligations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We incur retirement obligations for certain assets. We record initial liabilities for the asset retirement obligations ("ARO") at fair value. Recognition of ARO includes: estimating the present value of a liability and offsetting asset, the subsequent accretion of that liability and depletion of the asset, and a periodic review of the ARO liability estimates and discount rates used in the analysis. We provide additional information about our asset retirement obligations in Note 5 titled, “Property, Plant, and Equipment.”</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions of Business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Assets acquired and liabilities assumed in a business combination are accounted for at fair value on the date of acquisition. Costs related to the acquisition are expensed as incurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We perform our annual impairment test for goodwill in the third quarter of each year. We may consider qualitative indicators of the fair value of a reporting unit when it is unlikely that a reporting unit has impaired goodwill. We may also utilize a discounted cash flow analysis that requires certain assumptions and estimates be made regarding market conditions and our future profitability. We review the book value compared to the fair value at the reporting unit level. We calculate the fair value of our reporting units based on the present value of estimated future cash flows. Management's judgment is necessary to evaluate the impact of operating and macroeconomic changes and to estimate future cash flows to measure fair value. Assumptions used in our impairment evaluations, such as forecasted growth rates and cost of capital, are consistent with internal projections, strategic plans, and operating plans. We believe such assumptions and estimates are also comparable to those that would be used by other marketplace participants.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Self-Insurance Liabilities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We record a liability for self-insured risks that we retain for general and product liabilities, workers’ compensation, and automobile liabilities based on actuarial calculations. We use our historical loss experience and actuarial methods to calculate the liability. This liability includes estimates for both losses and incurred but not reported claims. We review the assumptions used to calculate the estimated liability at least annually to evaluate the adequacy of the amount recorded. We maintain insurance policies to cover losses greater than our estimated liability, which are subject to the terms and conditions of those policies. We are also self-insured for certain employee medical claims. We estimate a liability for incurred but not reported claims based upon recent claims experience.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Benefit Plans. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We sponsor defined benefit pension plans. We also sponsor a post-retirement benefits plan for certain former employees. We determine our costs and obligations related to these plans by evaluating input from third-party professional advisers. These costs and obligations are affected by assumptions including the discount rate, expected long-term rate of return on plan assets, the annual rate of change in compensation for eligible employees, estimated changes in costs of healthcare benefits, and other factors. We review the assumptions used on an annual basis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize an asset for the overfunded status or a liability for the underfunded status of defined benefit pension and post-retirement benefits plans in our consolidated balance sheets. This amount is measured as the difference between the fair value of plan assets and the benefit obligation (the projected benefit obligation for pension plans and the accumulated post-retirement benefit obligation for other post-retirement benefit plans). Changes in the funded status of the plans are recorded in other comprehensive income in the year they occur. We measure plan assets and obligations as of the balance sheet date. We provide additional information about our pension and other post-retirement benefits plans in Note 9 titled, “Benefit Plans.”</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Except for long-term debt, our financial instruments are highly liquid or have short-term maturities. We provide additional information about the fair value of our financial instruments in Note 17 titled, “Fair Value Measurements.”</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Most of our operations use their local currency as their functional currency. Financial statements of subsidiaries are translated into U.S. dollars using the exchange rate at each balance sheet date for assets and liabilities and a weighted average exchange rate for each period for revenues, expenses, gains and losses. Translation adjustments for subsidiaries whose local currency is their functional currency are recorded as a component of accumulated other comprehensive income (loss) within equity. Transaction gains and losses resulting from fluctuations in currency exchange rates on transactions denominated in currencies other than the functional currency are recognized as incurred in the accompanying Consolidated Statements of Income, except for certain intercompany balances designated as long-term in nature.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward and Swap Contracts. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We enter into foreign currency forward contracts to hedge assets and liabilities denominated in foreign currencies, including intercompany transactions.We may also enter into commodity swap contracts to hedge price changes in nickel that impact raw materials included in our Cost of revenues. We may also hold forward foreign exchange contracts to hedge a portion of our expected non-U.S. dollar denominated earnings against our reporting currency, the U.S. dollar. We do not use derivative financial instruments for speculative purposes. These contracts are marked to market, with gains and losses recognized within Selling, general, and administrative expenses or Cost of revenues in the accompanying Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warranty.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Warranties are provided on the sale of certain of our products and services and an accrual for estimated future claims is recorded at the time revenue is recognized. We estimate warranty expense based primarily on historical warranty claim experience.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We record shipping and handling costs in costs of revenues. Shipping and handling costs charged to Customers are recorded as revenues in the period the product revenues are recognized.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Costs incurred for communicating, advertising and promoting our products are generally expensed when incurred as a component of Selling, general, and administrative expenses. We incurred $21,668, $15,599, and $6,795 of advertising costs during the years ended March 31, 2023, 2022, and 2021, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We incur research and development costs associated with commercial products and expense these costs as incurred. If a Customer reimburses us for research and development costs, the costs are charged to the related contracts as costs of revenues.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We defer income taxes for all temporary differences between pre-tax financial and taxable income and between the book and tax basis of assets and liabilities. We record valuation allowances to reduce net deferred tax assets to an amount that we expect will more-likely-than-not be realized. In making such a determination, we consider all available information, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies, and if applicable, any carryback claims that can be filed. In the event we were to determine that we would be able to realize our deferred income tax assets in the future in excess of their net recorded amount, we would make an adjustment to the valuation allowance which would reduce the provision for income taxes and the effective tax rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate uncertain tax positions in accordance with a two-step process. The first step is recognition: The determination of whether or not it is more-likely-than-not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, we presume that the position will be examined by the appropriate tax authority and that the tax authority will have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not threshold is measured to determine the amount of benefit to recognize in the financial statements. The measurement process requires the determination of the range of possible settlement amounts and the probability of achieving each of the possible settlements. The tax position is measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. No tax benefits are recognized for positions that do not meet the more-likely-than-not threshold. Tax positions that previously failed to meet the more-likely-than-not threshold are recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not recognition threshold are derecognized in the first subsequent financial reporting period in which the threshold is no longer met. We describe income taxes further in Note 8 titled, “Income Taxes.”</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We describe share-based compensation in Note 14 titled, “Share-Based Compensation.” We measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award. We record liability awards at fair value each reporting period and the change in fair value is reflected as share-based compensation expense in our Consolidated Statements of Income. The expense is classified as Cost of revenues, Selling, general, and administrative expenses or Research and development expenses in a manner consistent with the employee’s compensation and benefits. These costs are recognized in the Consolidated Statements of Income over the period during which an employee is required to provide service in exchange for the award. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We recognize restructuring expenses as incurred. Asset impairment and accelerated depreciation expenses primarily relate to inventory write-downs for rationalized products and adjustments in the carrying value of the related facilities and machinery and equipment to their estimated fair value. In addition, the remaining useful lives of other property, plant, and equipment associated with the related operations are re-evaluated based on the respective restructuring plan, which may result in the acceleration of depreciation and amortization of certain assets. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Impacting the Company </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recently Issued Accounting Standards Impacting the Company are presented in the following table:</span></div><div style="margin-bottom:6pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:14.136%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.107%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.331%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.609%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Issuance</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Adoption</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect on the financial statements or other significant matters</span></td></tr><tr><td colspan="27" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standards that have been adopted in fiscal 2023.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2021-08 "Business Combinations (Topic 805) Accounting for Contract Assets and Contract Liabilities from Contracts with Customers."</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The standard provides guidance to improve the accounting for acquired revenue contracts with Customers in a business combination by addressing diversity in practice and inconsistency related to the recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. </span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Quarter Fiscal 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We adopted this standard effective April 1, 2022 with no material impact to our consolidated financial statements.</span></td></tr><tr><td colspan="27" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standards that have not yet been adopted.</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2022-04 "Liabilities - Supplier Finance Programs (Subtopic 405-50) Disclosure of Supplier Finance Program Obligations</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The standard provides guidance to enhance the transparency of disclosures for entities that utilize supplier finance programs to include information about the key terms of the programs and present a rollforward of any obligations under the program where those obligations are presented in the balance sheet.</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are in the process of evaluating the impact that the standard will have on our consolidated financial statements.</span></td></tr></table></div>

CY2023

us-gaap

Use Of Estimates

UseOfEstimates

<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We make certain estimates and assumptions when preparing financial statements according to U.S. GAAP that affect the reported amounts of assets and liabilities at the financial statement dates and the reported amounts of revenues and expenses during the periods presented. These estimates and assumptions involve judgments with respect to many factors that are difficult to predict and are beyond our control. Actual results could be materially different from these estimates. We revise the estimates and assumptions as new information becomes available.</span>

CY2023

ste

Business Combination Provisional Information Initial Accounting Incomplete Adjustment Lease Right Of Use Assets Net

BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLeaseRightOfUseAssetsNet

0

usd

CY2023

us-gaap

Interest Paid

InterestPaid

108470000

usd

CY2022

us-gaap

Interest Paid

InterestPaid

84696000

usd

CY2021

us-gaap

Interest Paid

InterestPaid

36257000

usd

CY2023

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

254661000

usd

CY2022

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

138382000

usd

CY2021

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

109646000

usd

CY2023

us-gaap

Proceeds From Income Tax Refunds

ProceedsFromIncomeTaxRefunds

2315000

usd

CY2022

us-gaap

Proceeds From Income Tax Refunds

ProceedsFromIncomeTaxRefunds

4605000

usd

CY2021

us-gaap

Proceeds From Income Tax Refunds

ProceedsFromIncomeTaxRefunds

4631000

usd

CY2023

us-gaap

Deferred Revenue Revenue Recognized1

DeferredRevenueRevenueRecognized1

78752000

usd

CY2022

us-gaap

Deferred Revenue Revenue Recognized1

DeferredRevenueRevenueRecognized1

46760000

usd

CY2023Q1

us-gaap

Revenue Remaining Performance Obligation

RevenueRemainingPerformanceObligation

1553461000

usd

CY2023

ste

Business Combination Provisional Information Initial Accounting Incomplete Adjustment Other Assets

BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets

0

usd

CY2023

us-gaap

Interest Costs Capitalized

InterestCostsCapitalized

6366000

usd

CY2022

us-gaap

Interest Costs Capitalized

InterestCostsCapitalized

3886000

usd

CY2023

us-gaap

Interest Costs Incurred

InterestCostsIncurred

107989000

usd

CY2022

us-gaap

Interest Costs Incurred

InterestCostsIncurred

89593000

usd

CY2021

us-gaap

Interest Costs Incurred

InterestCostsIncurred

37180000

usd

CY2023

us-gaap

Property Plant And Equipment Impairment

PropertyPlantAndEquipmentImpairment

<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Impairment Losses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Property, plant, equipment, and identifiable intangible assets are reviewed for impairment when indicators of impairment exist and circumstances indicate that the carrying value of such assets may not be recoverable. Impaired assets are recorded at the lower of carrying value or estimated fair value. We monitor for such indicators on an ongoing basis and if an impairment exists, we record the loss in the Consolidated Statements of Income during that period.</span>

CY2023

us-gaap

Business Combination Provisional Information Initial Accounting Incomplete Adjustment Intangibles

BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles

0

usd

CY2023

us-gaap

Advertising Expense

AdvertisingExpense

21668000

usd

CY2022

us-gaap

Advertising Expense

AdvertisingExpense

15599000

usd

CY2021

us-gaap

Advertising Expense

AdvertisingExpense

6795000

usd

CY2023

ste

Business Combination Provisional Information Initial Accounting Incomplete Adjustment Convertible Debt Par Value

BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConvertibleDebtParValue

0

usd

CY2022Q1

dei

Entity Number Of Employees

EntityNumberOfEmployees

3700

CY2022Q1

ste

Cantel Acquisition Assumed Debt Obligations

CantelAcquisitionAssumedDebtObligations

721284000

usd

CY2023

us-gaap

Goodwill Impairment Loss

GoodwillImpairmentLoss

490565000

usd

CY2023

ste

Business Combination Provisional Information Initial Accounting Incomplete Adjustment Cash

BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCash

0

usd

CY2023

ste

Business Combination Provisional Information Initial Accounting Incomplete Adjustment Accounts Receivable

BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable

0

usd

CY2023

us-gaap

Business Combination Provisional Information Initial Accounting Incomplete Adjustment Inventory

BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory

0

usd

CY2023

ste

Business Combination Provisional Information Initial Accounting Incomplete Adjustment Long Term Lease Obligations

BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermLeaseObligations

0

usd

CY2023

ste

Business Combination Provisional Information Initial Accounting Incomplete Adjustment Long Term Indebtedness

BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermIndebtedness

0

usd

CY2023

ste

Business Combination Provisional Information Initial Accounting Incomplete Adjustment Net Assets Acquired

BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired

0

usd

CY2022Q1

ste

Contingent Consideration Liability Assumed In Cantel Combination

ContingentConsiderationLiabilityAssumedInCantelCombination

25000000

usd

CY2022

ste

Net Sales Attributable To Cantel

NetSalesAttributableToCantel

974408000

usd

CY2022

ste

Operating Loss Income Attributable To Cantel

OperatingLossIncomeAttributableToCantel

41757000

usd

CY2022

us-gaap

Business Acquisitions Pro Forma Revenue

BusinessAcquisitionsProFormaRevenue

4790161000

usd

CY2021

us-gaap

Business Acquisitions Pro Forma Revenue

BusinessAcquisitionsProFormaRevenue

4190244000

usd

CY2022

us-gaap

Business Acquisitions Pro Forma Net Income Loss

BusinessAcquisitionsProFormaNetIncomeLoss

449382000

usd

CY2021

us-gaap

Business Acquisitions Pro Forma Net Income Loss

BusinessAcquisitionsProFormaNetIncomeLoss

5849000

usd

CY2022Q1

ste

Deferred Consideration

DeferredConsideration

50000

usd

CY2023Q1

us-gaap

Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount

BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount

4863000

usd

CY2022Q1

us-gaap

Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount

BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount

427035000

usd

CY2021Q1

us-gaap

Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount

BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount

197344000

usd

CY2023

us-gaap

Business Combination Acquisition Related Costs

BusinessCombinationAcquisitionRelatedCosts

24196000

usd

CY2022

us-gaap

Business Combination Acquisition Related Costs

BusinessCombinationAcquisitionRelatedCosts

205788000

usd

CY2021

us-gaap

Business Combination Acquisition Related Costs

BusinessCombinationAcquisitionRelatedCosts

35634000

usd

CY2021Q1

us-gaap

Goodwill

3026049000

usd

CY2022

us-gaap

Goodwill Acquired During Period

GoodwillAcquiredDuringPeriod

1522381000

usd

CY2022

us-gaap

Goodwill Purchase Accounting Adjustments

GoodwillPurchaseAccountingAdjustments

-15819000

usd

CY2022

ste

Goodwill Decrease From Divestitures

GoodwillDecreaseFromDivestitures

-7000000

usd

CY2022

us-gaap

Goodwill Foreign Currency Translation Gain Loss

GoodwillForeignCurrencyTranslationGainLoss

-121268000

usd

CY2022Q1

us-gaap

Goodwill

4404343000

usd

CY2023

us-gaap

Goodwill Acquired During Period

GoodwillAcquiredDuringPeriod

7024000

usd

CY2023

us-gaap

Goodwill Purchase Accounting Adjustments

GoodwillPurchaseAccountingAdjustments

22088000

usd

CY2023

us-gaap

Goodwill Impairment Loss

GoodwillImpairmentLoss

490565000

usd

CY2023

us-gaap

Goodwill Written Off Related To Sale Of Business Unit

GoodwillWrittenOffRelatedToSaleOfBusinessUnit

2358000

usd

CY2023

us-gaap

Goodwill Foreign Currency Translation Gain Loss

GoodwillForeignCurrencyTranslationGainLoss

-61313000

usd

CY2023Q1

us-gaap

Goodwill

3879219000

usd

CY2023

us-gaap

Goodwill Impairment Loss

GoodwillImpairmentLoss

490565000

usd

CY2023Q1

us-gaap

Finite Lived Intangible Assets Gross

FiniteLivedIntangibleAssetsGross

4181098000

usd

CY2023Q1

us-gaap

Finite Lived Intangible Assets Accumulated Amortization

FiniteLivedIntangibleAssetsAccumulatedAmortization

1225318000

usd

CY2022Q1

us-gaap

Finite Lived Intangible Assets Gross

FiniteLivedIntangibleAssetsGross

4185318000

usd

CY2022Q1

us-gaap

Finite Lived Intangible Assets Accumulated Amortization

FiniteLivedIntangibleAssetsAccumulatedAmortization

856781000

usd

CY2023Q1

us-gaap

Indefinite Lived Intangible Assets Excluding Goodwill

IndefiniteLivedIntangibleAssetsExcludingGoodwill

14250000

usd

CY2023

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

379752000

usd

CY2022

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

368698000

usd

CY2021

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

86512000

usd

CY2023Q1

us-gaap

Finite Lived Intangible Assets Amortization Expense Next Twelve Months

FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

369358000

usd

CY2023Q1

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Two

FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

363499000

usd

CY2023Q1

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Three

FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

354672000

usd

CY2023Q1

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Four

FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

348506000

usd

CY2023Q1

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Five

FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

343510000

usd

CY2023Q1

us-gaap

Inventory Raw Materials

InventoryRawMaterials

239081000

usd

CY2022Q1

us-gaap

Inventory Raw Materials

InventoryRawMaterials

195035000

usd

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

6502000

usd

CY2023Q1

us-gaap

Inventory Work In Process

InventoryWorkInProcess

97756000

usd

CY2022Q1

us-gaap

Inventory Work In Process

InventoryWorkInProcess

76021000

usd

CY2023Q1

us-gaap

Inventory Finished Goods

InventoryFinishedGoods

404238000

usd

CY2022Q1

us-gaap

Inventory Finished Goods

InventoryFinishedGoods

334880000

usd

CY2023Q1

us-gaap

Inventory Valuation Reserves

InventoryValuationReserves

45582000

usd

CY2022Q1

us-gaap

Inventory Valuation Reserves

InventoryValuationReserves

30937000

usd

CY2023Q1

us-gaap

Inventory Net

InventoryNet

695493000

usd

CY2022Q1

us-gaap

Inventory Net

InventoryNet

574999000

usd

CY2023Q1

us-gaap

Land

84313000

usd

CY2022Q1

us-gaap

Land

84015000

usd

CY2023Q1

us-gaap

Buildings And Improvements Gross

BuildingsAndImprovementsGross

691933000

usd

CY2022Q1

us-gaap

Buildings And Improvements Gross

BuildingsAndImprovementsGross

654851000

usd

CY2023Q1

us-gaap

Machinery And Equipment Gross

MachineryAndEquipmentGross

994188000

usd

CY2022Q1

us-gaap

Machinery And Equipment Gross

MachineryAndEquipmentGross

903649000

usd

CY2023Q1

ste

Computer Softwareand Hardwaregross

ComputerSoftwareandHardwaregross

247873000

usd

CY2022Q1

ste

Computer Softwareand Hardwaregross

ComputerSoftwareandHardwaregross

222620000

usd

CY2023Q1

us-gaap

Materials Supplies And Other

MaterialsSuppliesAndOther

637920000

usd

CY2022Q1

us-gaap

Materials Supplies And Other

MaterialsSuppliesAndOther

597641000

usd

CY2023Q1

us-gaap

Construction In Progress Gross

ConstructionInProgressGross

478316000

usd

CY2022Q1

us-gaap

Construction In Progress Gross

ConstructionInProgressGross

356013000

usd

CY2023Q1

us-gaap

Property Plant And Equipment Gross

PropertyPlantAndEquipmentGross

3134543000

usd

CY2022Q1

us-gaap

Property Plant And Equipment Gross

PropertyPlantAndEquipmentGross

2818789000

usd

CY2023Q1

us-gaap

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

1429031000

usd

CY2022Q1

us-gaap

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

1266213000

usd

CY2023Q1

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

1705512000

usd

CY2022Q1

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

1552576000

usd

CY2023

us-gaap

Depreciation

173145000

usd

CY2022

us-gaap

Depreciation

184406000

usd

CY2021

us-gaap

Depreciation

132725000

usd

CY2022Q1

ste

Term Loan Current Portion

TermLoanCurrentPortion

27500000

usd

CY2021Q1

us-gaap

Asset Retirement Obligation

AssetRetirementObligation

13330000

usd

CY2022

us-gaap

Asset Retirement Obligation Liabilities Incurred

AssetRetirementObligationLiabilitiesIncurred

86000

usd

CY2022

us-gaap

Asset Retirement Obligation Liabilities Settled

AssetRetirementObligationLiabilitiesSettled

3000

usd

CY2022

us-gaap

Asset Retirement Obligation Accretion Expense

AssetRetirementObligationAccretionExpense

146000

usd

CY2022

us-gaap

Asset Retirement Obligation Foreign Currency Translation Gain Loss

AssetRetirementObligationForeignCurrencyTranslationGainLoss

-16000

usd

CY2022Q1

us-gaap

Asset Retirement Obligation

AssetRetirementObligation

13543000

usd

CY2023

us-gaap

Asset Retirement Obligation Liabilities Incurred

AssetRetirementObligationLiabilitiesIncurred

86000

usd

CY2023

us-gaap

Asset Retirement Obligation Liabilities Settled

AssetRetirementObligationLiabilitiesSettled

625000

usd

CY2023

us-gaap

Asset Retirement Obligation Accretion Expense

AssetRetirementObligationAccretionExpense

104000

usd

CY2023

us-gaap

Asset Retirement Obligation Foreign Currency Translation Gain Loss

AssetRetirementObligationForeignCurrencyTranslationGainLoss

23000

usd

CY2023Q1

us-gaap

Asset Retirement Obligation

AssetRetirementObligation

13131000

usd

CY2023Q1

ste

Term Loan Current Portion

TermLoanCurrentPortion

27500000

usd

CY2023Q1

ste

Delayed Draw Term Loan Current Portion

DelayedDrawTermLoanCurrentPortion

32500000

usd

CY2022Q1

ste

Delayed Draw Term Loan Current Portion

DelayedDrawTermLoanCurrentPortion

24375000

usd

CY2023Q1

us-gaap

Short Term Borrowings

ShortTermBorrowings

60000000

usd

CY2022Q1

us-gaap

Short Term Borrowings

ShortTermBorrowings

142875000

usd

CY2023Q1

us-gaap

Line Of Credit

LineOfCredit

301672000

usd

CY2022Q1

us-gaap

Line Of Credit

LineOfCredit

58908000

usd

CY2023Q1

us-gaap

Deferred Finance Costs Net

DeferredFinanceCostsNet

21444000

usd

CY2022Q1

us-gaap

Deferred Finance Costs Net

DeferredFinanceCostsNet

25278000

usd

CY2023Q1

ste

Term Loan Long Term Portion

TermLoanLongTermPortion

45000000

usd

CY2022Q1

ste

Term Loan Long Term Portion

TermLoanLongTermPortion

177500000

usd

CY2023Q1

ste

Delayed Draw Term Loan Long Term Portion

DelayedDrawTermLoanLongTermPortion

593125000

usd

CY2022Q1

ste

Delayed Draw Term Loan Long Term Portion

DelayedDrawTermLoanLongTermPortion

625625000

usd

CY2023Q1

us-gaap

Long Term Debt

LongTermDebt

3018655000

usd

CY2022Q1

us-gaap

Long Term Debt

LongTermDebt

2945481000

usd

CY2023Q1

us-gaap

Debt Longterm And Shortterm Combined Amount

DebtLongtermAndShorttermCombinedAmount

3078655000

usd

CY2022Q1

us-gaap

Debt Longterm And Shortterm Combined Amount

DebtLongtermAndShorttermCombinedAmount

3088356000

usd

CY2023Q1

us-gaap

Line Of Credit

LineOfCredit

301672000

usd

CY2022Q2

ste

Delayed Draw Term Loan Long Term Portion

DelayedDrawTermLoanLongTermPortion

650000000

usd

CY2021Q2

ste

Business Acquisition Shares Received Per Ordinary Share

BusinessAcquisitionSharesReceivedPerOrdinaryShare

0.33787

shares

CY2021Q2

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.001

CY2021Q2

ste

Debt Instrument Convertible Units Of Property Reference

DebtInstrumentConvertibleUnitsOfPropertyReference

25.0843

CY2021Q2

ste

Debt Instrument Convertible Parent Shares

DebtInstrumentConvertibleParentShares

8.4752

shares

CY2021Q2

ste

Debt Instrument Convertible Cash Per One Thousand Dollars Ratio

DebtInstrumentConvertibleCashPerOneThousandDollarsRatio

424.68

CY2021Q2

ste

Debt Instrument Convertible Increase In Conversion Rate Shares

DebtInstrumentConvertibleIncreaseInConversionRateShares

0.9931

shares

CY2021Q2

ste

Debt Instrument Convertible Stock Price

DebtInstrumentConvertibleStockPrice

81.3520

CY2022

ste

Consideration Related To Equity Component Of Convertible Debt

ConsiderationRelatedToEquityComponentOfConvertibleDebt

175555000

usd

CY2023Q1

ste

Convertible Debt Premium Liability

ConvertibleDebtPremiumLiability

203361000

usd

CY2023Q1

us-gaap

Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months

LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths

60000000

usd

CY2023Q1

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Two

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo

165938000

usd

CY2023Q1

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Three

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree

479173000

usd

CY2023Q1

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Four

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour

614942000

usd

CY2023Q1

us-gaap

Long Term Debt Maturities Repayments Of Principal After Year Five

LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive

1780047000

usd

CY2023Q1

ste

Long Term Debt Excluding Deferred Financing Fees

LongTermDebtExcludingDeferredFinancingFees

3100100000

usd

CY2023Q1

us-gaap

Employee Related Liabilities Current And Noncurrent

EmployeeRelatedLiabilitiesCurrentAndNoncurrent

48565000

usd

CY2022Q1

us-gaap

Employee Related Liabilities Current And Noncurrent

EmployeeRelatedLiabilitiesCurrentAndNoncurrent

71878000

usd

CY2023Q1

us-gaap

Accrued Vacation Current And Noncurrent

AccruedVacationCurrentAndNoncurrent

11080000

usd

CY2022Q1

us-gaap

Accrued Vacation Current And Noncurrent

AccruedVacationCurrentAndNoncurrent

13669000

usd

CY2023Q1

us-gaap

Accrued Bonuses Current And Noncurrent

AccruedBonusesCurrentAndNoncurrent

33605000

usd

CY2022Q1

us-gaap

Accrued Bonuses Current And Noncurrent

AccruedBonusesCurrentAndNoncurrent

64702000

usd

CY2023Q1

us-gaap

Accrued Liabilities For Commissions Expense And Taxes

AccruedLiabilitiesForCommissionsExpenseAndTaxes

29257000

usd

CY2022Q1

us-gaap

Accrued Liabilities For Commissions Expense And Taxes

AccruedLiabilitiesForCommissionsExpenseAndTaxes

30171000

usd

CY2023Q1

us-gaap

Other Postretirement Benefits Payable Current And Noncurrent

OtherPostretirementBenefitsPayableCurrentAndNoncurrent

1121000

usd

CY2022Q1

us-gaap

Other Postretirement Benefits Payable Current And Noncurrent

OtherPostretirementBenefitsPayableCurrentAndNoncurrent

1190000

usd

CY2023Q1

us-gaap

Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current And Noncurrent

PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrentAndNoncurrent

2014000

usd

CY2022Q1

us-gaap

Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current And Noncurrent

PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrentAndNoncurrent

2111000

usd

CY2023Q1

us-gaap

Employee Related Liabilities Current

EmployeeRelatedLiabilitiesCurrent

125642000

usd

CY2022Q1

us-gaap

Employee Related Liabilities Current

EmployeeRelatedLiabilitiesCurrent

183721000

usd

CY2023Q1

us-gaap

Deferred Revenue

DeferredRevenue

92283000

usd

CY2022Q1

us-gaap

Deferred Revenue

DeferredRevenue

110791000

usd

CY2023Q1

ste

Serviceliabilities

72033000

usd

CY2022Q1

ste

Serviceliabilities

51365000

usd

CY2023Q1

us-gaap

Self Insurance Reserve Current

SelfInsuranceReserveCurrent

11325000

usd

CY2022Q1

us-gaap

Self Insurance Reserve Current

SelfInsuranceReserveCurrent

8995000

usd

CY2023Q1

ste

Accrued Dealerand Distributor Commissions

AccruedDealerandDistributorCommissions

31096000

usd

CY2022Q1

ste

Accrued Dealerand Distributor Commissions

AccruedDealerandDistributorCommissions

31700000

usd

CY2023Q1

us-gaap

Product Warranty Accrual

ProductWarrantyAccrual

13683000

usd

CY2022Q1

us-gaap

Product Warranty Accrual

ProductWarrantyAccrual

14108000

usd

CY2023Q1

us-gaap

Asset Retirement Obligation Current

AssetRetirementObligationCurrent

543000

usd

CY2022Q1

us-gaap

Asset Retirement Obligation Current

AssetRetirementObligationCurrent

1181000

usd

CY2023Q1

ste

Accrued Interest

AccruedInterest

9243000

usd

CY2022Q1

ste

Accrued Interest

AccruedInterest

10014000

usd

CY2023Q1

us-gaap

Other Accrued Liabilities Current And Noncurrent

OtherAccruedLiabilitiesCurrentAndNoncurrent

87611000

usd

CY2022Q1

us-gaap

Other Accrued Liabilities Current And Noncurrent

OtherAccruedLiabilitiesCurrentAndNoncurrent

78390000

usd

CY2023Q1

us-gaap

Accrued Liabilities Current And Noncurrent

AccruedLiabilitiesCurrentAndNoncurrent

317817000

usd

CY2022Q1

us-gaap

Accrued Liabilities Current And Noncurrent

AccruedLiabilitiesCurrentAndNoncurrent

306544000

usd

CY2023Q1

us-gaap

Self Insurance Reserve Noncurrent

SelfInsuranceReserveNoncurrent

22171000

usd

CY2022Q1

us-gaap

Self Insurance Reserve Noncurrent

SelfInsuranceReserveNoncurrent

19213000

usd

CY2023Q1

us-gaap

Other Postretirement Benefits Payable Noncurrent

OtherPostretirementBenefitsPayableNoncurrent

6070000

usd

CY2022Q1

us-gaap

Other Postretirement Benefits Payable Noncurrent

OtherPostretirementBenefitsPayableNoncurrent

7335000

usd

CY2023Q1

us-gaap

Defined Benefit Pension Plan Liabilities Noncurrent

DefinedBenefitPensionPlanLiabilitiesNoncurrent

2876000

usd

CY2022Q1

us-gaap

Defined Benefit Pension Plan Liabilities Noncurrent

DefinedBenefitPensionPlanLiabilitiesNoncurrent

1772000

usd

CY2023Q1

us-gaap

Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent

PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent

1153000

usd

CY2022Q1

us-gaap

Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent

PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent

1360000

usd

CY2023Q1

us-gaap

Accrued Income Taxes Noncurrent

AccruedIncomeTaxesNoncurrent

10082000

usd

CY2022Q1

us-gaap

Accrued Income Taxes Noncurrent

AccruedIncomeTaxesNoncurrent

12225000

usd

CY2023Q1

us-gaap

Asset Retirement Obligations Noncurrent

AssetRetirementObligationsNoncurrent

12588000

usd

CY2022Q1

us-gaap

Asset Retirement Obligations Noncurrent

AssetRetirementObligationsNoncurrent

12362000

usd

CY2023Q1

us-gaap

Other Liabilities

OtherLiabilities

21197000

usd

CY2022Q1

us-gaap

Other Liabilities

OtherLiabilities

21312000

usd

CY2023Q1

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

76137000

usd

CY2022Q1

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

75579000

usd

CY2023

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

157348000

usd

CY2022

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

314503000

usd

CY2021

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

517533000

usd

CY2023

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

33234000

usd

CY2022

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

21438000

usd

CY2021

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

16272000

usd

CY2023

us-gaap

Current Federal Tax Expense Benefit

CurrentFederalTaxExpenseBenefit

8837000

usd

CY2022

us-gaap

Current Federal Tax Expense Benefit

CurrentFederalTaxExpenseBenefit

12002000

usd

CY2021

us-gaap

Current Federal Tax Expense Benefit

CurrentFederalTaxExpenseBenefit

9244000

usd

CY2023

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

241725000

usd

CY2022

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

174952000

usd

CY2021

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

119765000

usd

CY2023

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

-50530000

usd

CY2022

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

-17124000

usd

CY2021

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

-550000

usd

CY2023

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

-864000

usd

CY2022

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

-739000

usd

CY2021

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

-787000

usd

CY2023

us-gaap

Increase Decrease In Deferred Income Taxes

IncreaseDecreaseInDeferredIncomeTaxes

-190190000

usd

CY2022

us-gaap

Increase Decrease In Deferred Income Taxes

IncreaseDecreaseInDeferredIncomeTaxes

-103319000

usd

CY2021

us-gaap

Increase Decrease In Deferred Income Taxes

IncreaseDecreaseInDeferredIncomeTaxes

898000

usd

CY2023

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

51535000

usd

CY2022

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

71633000

usd

CY2021

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

120663000

usd

CY2023

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.125

CY2022

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.125

CY2021

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.125

CY2023

ste

Effective Tax Rate Reconciliation Increasedecreaseforuncertaintaxpositions

EffectiveTaxRateReconciliationIncreasedecreaseforuncertaintaxpositions

-0.001

CY2022

ste

Effective Tax Rate Reconciliation Increasedecreaseforuncertaintaxpositions

EffectiveTaxRateReconciliationIncreasedecreaseforuncertaintaxpositions

0.002

CY2021

ste

Effective Tax Rate Reconciliation Increasedecreaseforuncertaintaxpositions

EffectiveTaxRateReconciliationIncreasedecreaseforuncertaintaxpositions

-0.001

CY2023

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

-0.108

CY2022

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

0.014

CY2021

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

0.024

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

-0.001

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

0.009

CY2021

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

0.003

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Tax Credits Research

EffectiveIncomeTaxRateReconciliationTaxCreditsResearch

0.018

CY2022Q1

us-gaap

Income Tax Examination Penalties And Interest Accrued

IncomeTaxExaminationPenaltiesAndInterestAccrued

152000

usd

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Tax Credits Research

EffectiveIncomeTaxRateReconciliationTaxCreditsResearch

0.008

CY2021

us-gaap

Effective Income Tax Rate Reconciliation Tax Credits Research

EffectiveIncomeTaxRateReconciliationTaxCreditsResearch

0.005

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Tax Credits Foreign

EffectiveIncomeTaxRateReconciliationTaxCreditsForeign

0.012

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Tax Credits Foreign

EffectiveIncomeTaxRateReconciliationTaxCreditsForeign

0.011

CY2021

us-gaap

Effective Income Tax Rate Reconciliation Tax Credits Foreign

EffectiveIncomeTaxRateReconciliationTaxCreditsForeign

0.003

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential

EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential

0.086

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential

EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential

0.126

CY2021

us-gaap

Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential

EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential

0.083

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Tax Settlements

EffectiveIncomeTaxRateReconciliationTaxSettlements

0

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Tax Settlements

EffectiveIncomeTaxRateReconciliationTaxSettlements

0

CY2021

us-gaap

Effective Income Tax Rate Reconciliation Tax Settlements

EffectiveIncomeTaxRateReconciliationTaxSettlements

0.021

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses

EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses

0.290

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses

EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses

0

CY2021

us-gaap

Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses

EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses

0

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent

EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent

-0.027

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent

EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent

-0.051

CY2021

us-gaap

Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent

EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent

-0.019

CY2023

ste

Effective Tax Reconciliationdeferredtaxassetsandliabilities

EffectiveTaxReconciliationdeferredtaxassetsandliabilities

0.004

CY2022

ste

Effective Tax Reconciliationdeferredtaxassetsandliabilities

EffectiveTaxReconciliationdeferredtaxassetsandliabilities

0.023

CY2021

ste

Effective Tax Reconciliationdeferredtaxassetsandliabilities

EffectiveTaxReconciliationdeferredtaxassetsandliabilities

0.004

CY2023

ste

U.S.Taxreformimpact Gilt Iand Fdii

U.S.taxreformimpactGILTIandFDII

-0.013

CY2022

ste

U.S.Taxreformimpact Gilt Iand Fdii

U.S.taxreformimpactGILTIandFDII

-0.009

CY2021

ste

U.S.Taxreformimpact Gilt Iand Fdii

U.S.taxreformimpactGILTIandFDII

-0.006

CY2023

ste

Capitalized Interest Costs Effectivetaxrate

CapitalizedInterestCostsEffectivetaxrate

0

CY2022

ste

Capitalized Interest Costs Effectivetaxrate

CapitalizedInterestCostsEffectivetaxrate

0.018

CY2021

ste

Capitalized Interest Costs Effectivetaxrate

CapitalizedInterestCostsEffectivetaxrate

0.006

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

0.003

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

-0.010

CY2021

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

0.001

CY2023

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.328

CY2022

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.228

CY2021

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.233

CY2022Q1

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

2906000

usd

CY2021Q1

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

2295000

usd

CY2023

us-gaap

Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions

UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions

63000

usd

CY2022

us-gaap

Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions

UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions

0

usd

CY2023

us-gaap

Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions

UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions

0

usd

CY2022

us-gaap

Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions

UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions

135000

usd

CY2023

us-gaap

Unrecognized Tax Benefits Decreases Resulting From Acquisition

UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition

503000

usd

CY2022

us-gaap

Unrecognized Tax Benefits Increases Resulting From Acquisition

UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition

746000

usd

CY2023

us-gaap

Unrecognized Tax Benefits Increases Resulting From Foreign Currency Translation

UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation

21000

usd

CY2022

us-gaap

Unrecognized Tax Benefits Increases Resulting From Foreign Currency Translation

UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation

0

usd

CY2023Q1

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

2487000

usd

CY2022Q1

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

2906000

usd

CY2023Q1

us-gaap

Income Tax Examination Penalties And Interest Accrued

IncomeTaxExaminationPenaltiesAndInterestAccrued

152000

usd

CY2023Q1

us-gaap

Unrecognized Tax Benefits That Would Impact Effective Tax Rate

UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate

2640000

usd

CY2023Q1

ste

Uncertain Tax Liability Resulting From Irs Notice

UncertainTaxLiabilityResultingFromIRSNotice

12000000

usd

CY2023Q1

ste

Irs Settlement Paid

IRSSettlementPaid

7500000

usd

CY2021Q2

ste

Uncertain Tax Liability Resulting From Irs Notice

UncertainTaxLiabilityResultingFromIRSNotice

50000000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits

DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits

1737000

usd

CY2022Q1

us-gaap

Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits

DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits

2086000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Tax Deferred Expense Compensation And Benefits

DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits

15858000

usd

CY2022Q1

us-gaap

Deferred Tax Assets Tax Deferred Expense Compensation And Benefits

DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits

14340000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Operating Loss Carryforwards

DeferredTaxAssetsOperatingLossCarryforwards

37667000

usd

CY2022Q1

us-gaap

Deferred Tax Assets Operating Loss Carryforwards

DeferredTaxAssetsOperatingLossCarryforwards

25550000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities

13150000

usd

CY2022Q1

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities

12092000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance

2268000

usd

CY2022Q1

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance

2561000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Deferred Income

DeferredTaxAssetsDeferredIncome

23967000

usd

CY2022Q1

us-gaap

Deferred Tax Assets Deferred Income

DeferredTaxAssetsDeferredIncome

20688000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts

3763000

usd

CY2022Q1

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts

2187000

usd

CY2023Q1

us-gaap

Deferred Tax Assets In Process Research And Development

DeferredTaxAssetsInProcessResearchAndDevelopment

15382000

usd

CY2022Q1

us-gaap

Deferred Tax Assets In Process Research And Development

DeferredTaxAssetsInProcessResearchAndDevelopment

0

usd

CY2023Q1

ste

Deferred Tax Assets Operatingleases

DeferredTaxAssetsOperatingleases

46781000

usd

CY2022Q1

ste

Deferred Tax Assets Operatingleases

DeferredTaxAssetsOperatingleases

44401000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Tax Credit Carryforwards Foreign

DeferredTaxAssetsTaxCreditCarryforwardsForeign

33559000

usd

CY2022Q1

us-gaap

Deferred Tax Assets Tax Credit Carryforwards Foreign

DeferredTaxAssetsTaxCreditCarryforwardsForeign

36036000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Other

DeferredTaxAssetsOther

11701000

usd

CY2022Q1

us-gaap

Deferred Tax Assets Other

DeferredTaxAssetsOther

8579000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

205833000

usd

CY2022Q1

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

168520000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

20315000

usd

CY2022Q1

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

24691000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Net

DeferredTaxAssetsNet

185518000

usd

CY2022Q1

us-gaap

Deferred Tax Assets Net

DeferredTaxAssetsNet

143829000

usd

CY2023Q1

us-gaap

Deferred Tax Liabilities Property Plant And Equipment

DeferredTaxLiabilitiesPropertyPlantAndEquipment

98601000

usd

CY2022Q1

us-gaap

Deferred Tax Liabilities Property Plant And Equipment

DeferredTaxLiabilitiesPropertyPlantAndEquipment

110951000

usd

CY2023Q1

us-gaap

Deferred Tax Liabilities Leasing Arrangements

DeferredTaxLiabilitiesLeasingArrangements

45834000

usd

CY2022Q1

us-gaap

Deferred Tax Liabilities Leasing Arrangements

DeferredTaxLiabilitiesLeasingArrangements

43593000

usd

CY2023Q1

us-gaap

Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets

DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets

630589000

usd

CY2022Q1

us-gaap

Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets

DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets

755980000

usd

CY2023Q1

ste

Deferred Tax Liabilities Pension

DeferredTaxLiabilitiesPension

2644000

usd

CY2022Q1

ste

Deferred Tax Liabilities Pension

DeferredTaxLiabilitiesPension

2004000

usd

CY2023Q1

us-gaap

Deferred Tax Liabilities Other

DeferredTaxLiabilitiesOther

3186000

usd

CY2022Q1

us-gaap

Deferred Tax Liabilities Other

DeferredTaxLiabilitiesOther

3473000

usd

CY2023Q1

us-gaap

Deferred Income Tax Liabilities

DeferredIncomeTaxLiabilities

780854000

usd

CY2022Q1

us-gaap

Deferred Income Tax Liabilities

DeferredIncomeTaxLiabilities

916001000

usd

CY2023Q1

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

595336000

usd

CY2022Q1

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

772172000

usd

CY2023Q1

us-gaap

Operating Loss Carryforwards

OperatingLossCarryforwards

9407000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Operating Loss Carryforwards Foreign

DeferredTaxAssetsOperatingLossCarryforwardsForeign

126443000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Operating Loss Carryforwards State And Local

DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal

3391000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Tax Credit Carryforwards

DeferredTaxAssetsTaxCreditCarryforwards

35220000

usd

CY2023Q1

ste

Deferred Tax Asset Credit Carryforward German Branches

DeferredTaxAssetCreditCarryforwardGermanBranches

26728000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

20315000

usd

CY2023

us-gaap

Valuation Allowance Deferred Tax Asset Change In Amount

ValuationAllowanceDeferredTaxAssetChangeInAmount

-4376000

usd

CY2023Q1

us-gaap

Undistributed Earnings Of Foreign Subsidiaries

UndistributedEarningsOfForeignSubsidiaries

1915000000

usd

CY2008Q3

us-gaap

Defined Benefit Plan Accumulated Benefit Obligation

DefinedBenefitPlanAccumulatedBenefitObligation

46001000

usd

CY2023

us-gaap

Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax

OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax

750000

usd

CY2023Q1

us-gaap

Defined Benefit Plan Accumulated Other Comprehensive Income Before Tax

DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax

-5602000

usd

CY2023Q1

us-gaap

Defined Benefit Plan Health Care Cost Trend Rate Assumed Next Fiscal Year

DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear

0.0750

CY2022Q1

us-gaap

Defined Benefit Plan Health Care Cost Trend Rate Assumed Next Fiscal Year

DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear

0.0700

CY2021Q1

us-gaap

Defined Benefit Plan Health Care Cost Trend Rate Assumed Next Fiscal Year

DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear

0.0700

CY2023Q1

ste

Healthcare Prescription Drug

HealthcarePrescriptionDrug

0.0750

CY2022Q1

ste

Healthcare Prescription Drug

HealthcarePrescriptionDrug

0.0700

CY2021Q1

ste

Healthcare Prescription Drug

HealthcarePrescriptionDrug

0.0700

CY2023Q1

us-gaap

Defined Benefit Plan Ultimate Health Care Cost Trend Rate1

DefinedBenefitPlanUltimateHealthCareCostTrendRate1

0.0450

CY2022Q1

us-gaap

Defined Benefit Plan Ultimate Health Care Cost Trend Rate1

DefinedBenefitPlanUltimateHealthCareCostTrendRate1

0.0450

CY2021Q1

us-gaap

Defined Benefit Plan Ultimate Health Care Cost Trend Rate1

DefinedBenefitPlanUltimateHealthCareCostTrendRate1

0.0450

CY2021Q1

us-gaap

Other Investments

OtherInvestments

5555000

usd

CY2022

us-gaap

Defined Benefit Plan Change In Fair Value Of Plan Assets Level3 Reconciliation Period Increase Decrease

DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationPeriodIncreaseDecrease

-115000

usd

CY2022

us-gaap

Defined Benefit Plan Plan Assets Foreign Currency Translation Gain Loss

DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss

153000

usd

CY2022Q1

us-gaap

Other Investments

OtherInvestments

5383000

usd

CY2023

us-gaap

Defined Benefit Plan Change In Fair Value Of Plan Assets Level3 Reconciliation Period Increase Decrease

DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationPeriodIncreaseDecrease

-157000

usd

CY2023

us-gaap

Defined Benefit Plan Plan Assets Foreign Currency Translation Gain Loss

DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss

-159000

usd

CY2023Q1

us-gaap

Other Investments

OtherInvestments

5387000

usd

CY2022

ste

Lettersofcreditassecurityforselfinsuranceriskandretentionpolicies

13900000

usd

CY2023Q1

us-gaap

Purchase Commitment Remaining Minimum Amount Committed

PurchaseCommitmentRemainingMinimumAmountCommitted

57221000

usd

CY2023

us-gaap

Defined Benefit Plan Plan Assets Prescription Drug Subsidy Receipt

DefinedBenefitPlanPlanAssetsPrescriptionDrugSubsidyReceipt

477000

usd

CY2022

us-gaap

Defined Benefit Plan Plan Assets Prescription Drug Subsidy Receipt

DefinedBenefitPlanPlanAssetsPrescriptionDrugSubsidyReceipt

660000

usd

CY2023Q1

ste

Defined Contribution Plan Fair Value Of Plan Assets

DefinedContributionPlanFairValueOfPlanAssets

1170835000

usd

CY2023Q1

ste

Steris Corporation Shares Held In Defined Contribution Plan

SterisCorporationSharesHeldInDefinedContributionPlan

483931

shares

CY2023Q1

ste

Fair Value Of Steris Corporatio Stock Held In Defined Contribution Plan

FairValueOfSterisCorporatioStockHeldInDefinedContributionPlan

92566000

usd

CY2023Q1

ste

Defined Contribution Plan Dividends Paid

DefinedContributionPlanDividendsPaid

886000

usd

CY2022Q1

ste

Defined Contribution Plan Dividends Paid

DefinedContributionPlanDividendsPaid

852000

usd

CY2021Q1

ste

Defined Contribution Plan Dividends Paid

DefinedContributionPlanDividendsPaid

839000

usd

CY2023

us-gaap

Defined Contribution Plan Employer Discretionary Contribution Amount

DefinedContributionPlanEmployerDiscretionaryContributionAmount

36564000

usd

CY2022

us-gaap

Defined Contribution Plan Employer Discretionary Contribution Amount

DefinedContributionPlanEmployerDiscretionaryContributionAmount

38600000

usd

CY2021

us-gaap

Defined Contribution Plan Employer Discretionary Contribution Amount

DefinedContributionPlanEmployerDiscretionaryContributionAmount

29853000

usd

CY2023Q1

us-gaap

Deferred Compensation Plan Assets

DeferredCompensationPlanAssets

938000

usd

CY2022Q1

us-gaap

Deferred Compensation Plan Assets

DeferredCompensationPlanAssets

1061000

usd

CY2023

us-gaap

Loss Contingency Disclosures

LossContingencyDisclosures

<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.COMMITMENTS AND CONTINGENCIES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are, and will likely continue to be, involved in a number of legal proceedings, government investigations, and claims, which we believe generally arise in the course of our business, given our size, history, complexity, and the nature of our business, products, Customers, regulatory environment, and industries in which we participate. These legal proceedings, investigations and claims generally involve a variety of legal theories and allegations, including, without limitation, personal injury (e.g., slip and falls, burns, vehicle accidents), product liability or regulation (e.g., based on product operation or claimed malfunction, failure to warn, failure to meet specification, or failure to comply with regulatory requirements), product exposure (e.g., claimed exposure to chemicals, gases, asbestos, contaminants, radiation), property damage (e.g., claimed damage due to leaking equipment, fire, vehicles, chemicals), commercial claims (e.g., breach of contract, economic loss, warranty, misrepresentation), financial (e.g., taxes, reporting), employment (e.g., wrongful termination, discrimination, benefits matters), and other claims for damage and relief.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe we have adequately reserved for our current litigation and claims that are probable and estimable, and further believe that the ultimate outcome of these pending lawsuits and claims will not have a material adverse effect on our consolidated financial position or results of operations taken as a whole. Due to their inherent uncertainty, however, there can be no assurance of the ultimate outcome or effect of current or future litigation, investigations, claims or other proceedings (including without limitation the matters discussed below). For certain types of claims, we presently maintain insurance coverage for personal injury and property damage and other liability coverages in amounts and with deductibles that we believe are prudent, but there can be no assurance that these coverages will be applicable or adequate to cover adverse outcomes of claims or legal proceedings against us.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Civil, criminal, regulatory or other proceedings involving our products or services could possibly result in judgments, settlements or administrative or judicial decrees requiring us, among other actions, to pay damages or fines or effect recalls, or be subject to other governmental, Customer or other third party claims or remedies, which could materially effect our business, performance, prospects, value, financial condition, and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding these matters, see the risks and uncertainties described under the title "product and service related regulations and claims" in Item 1A. of this Annual Report on Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, STERIS is also involved in legal proceedings as a plaintiff involving contract, patent protection, and other claims asserted by us. Gains, if any, from these proceedings are recognized when they are realized.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to taxation from United States federal, state and local, and foreign jurisdictions. Tax positions are settled primarily through the completion of audits within each individual jurisdiction or the closing of statutes of limitation. Changes in applicable tax law or other events may also require us to revise past estimates. We describe income taxes further in Note 8 to our consolidated financial statements titled, “Income Taxes” in t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">his Annual Report on Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023 and 2022, our commercial commitments totaled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$108,370</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $98,675, respectively. Commercial commitments include standby letters of credit, letters of credit required as security under our self-insured risk retention policies, and other potential cash outflows resulting from an event that requires payment by us. Approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$8,036</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $13,900 of the March 31, 2023 and 2022 totals, respectively, relate to letters of credit required as security under our self-ins</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ured risk retention policies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, we had minimum purchase commitments with suppliers for raw material purchases totaling </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$57,221</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of March 31, 2023, we also had commitments of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$194,505</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for long term construction contracts. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease manufacturing, warehouse and office space, service facilities, vehicles, equipment and communication systems. Certain leases contain options that provide us with the ability to extend the lease term. Such options are included in the lease term when it is reasonably certain that the option will be exercised. We made an accounting policy election to not recognize lease assets or lease liabilities for leases with a lease term of twelve months or less. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an agreement contains a lease and classify our leases as operating or finance at the lease commencement date. Finance leases are generally those leases for which we will pay substantially all the underlying asset’s fair value or will use the asset for all or a major part of its economic life, including circumstances in which we will ultimately own the asset. Lease assets arising from finance leases are included in Property, plant, and equipment, net and the liabilities are included in other liabilities. For finance leases, we recognize interest expense using the effective interest method and we recognize amortization expense on the lease asset over the shorter of the lease term or the useful life of the asset. Our finance leases are not material as of March 31, 2023 and for the twelve-month period then ended. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease assets and liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term. Lease assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. As most leases do not provide an implicit interest rate, we estimate an incremental borrowing rate to determine the present value of lease payments. Our estimated incremental borrowing rate reflects a secured rate based on recent debt issuances, our estimated credit rating, lease term, as well as publicly available data for instruments with similar characteristics. For operating leases, we recognize lease cost on a straight-line basis over the term of the lease. When accounting for leases, we combine payments for leased assets, related services and other components of a lease.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of operating lease expense are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed operating lease expense </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45,249</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,158 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable operating lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,486</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,659 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease expense</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,817 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.027%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45,249</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,144 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for operating lease obligations, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53,099</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,241 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities at March 31, 2023 are as follows</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.006%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,709</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,584</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,129</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,659</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">120,359</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">241,440</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45,986</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">195,454</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the preceding table, the future minimum annual rentals payable under noncancelable leases denominated in foreign currencies have been calculated using March 31, 2023 foreign currency exchange rates.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to operating leases is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.200%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term of operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.3 years</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6 years</span></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate of operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>

CY2023

ste

Lettersofcreditassecurityforselfinsuranceriskandretentionpolicies

8036000

usd

CY2023

ste

Fixed Operating Lease Expense

FixedOperatingLeaseExpense

45249000

usd

CY2022

ste

Fixed Operating Lease Expense

FixedOperatingLeaseExpense

45158000

usd

CY2023

ste

Variable Operating Lease Expense

VariableOperatingLeaseExpense

21486000

usd

CY2022

ste

Variable Operating Lease Expense

VariableOperatingLeaseExpense

12659000

usd

CY2023

us-gaap

Operating Lease Expense

OperatingLeaseExpense

66735000

usd

CY2022

us-gaap

Operating Lease Expense

OperatingLeaseExpense

57817000

usd

CY2023

us-gaap

Operating Lease Payments

OperatingLeasePayments

45249000

usd

CY2022

us-gaap

Operating Lease Payments

OperatingLeasePayments

45144000

usd

CY2023

us-gaap

Right Of Use Asset Obtained In Exchange For Operating Lease Liability

RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

53099000

usd

CY2022

us-gaap

Right Of Use Asset Obtained In Exchange For Operating Lease Liability

RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

79241000

usd

CY2023Q1

us-gaap

Lessee Operating Lease Liability Payments Due Next Twelve Months

LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths

41709000

usd

CY2023Q1

us-gaap

Lessee Operating Lease Liability Payments Due Year Two

LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

33584000

usd

CY2023Q1

us-gaap

Lessee Operating Lease Liability Payments Due Year Three

LesseeOperatingLeaseLiabilityPaymentsDueYearThree

26129000

usd

CY2023Q1

us-gaap

Lessee Operating Lease Liability Payments Due Year Four

LesseeOperatingLeaseLiabilityPaymentsDueYearFour

19659000

usd

CY2023Q1

us-gaap

Lessee Operating Lease Liability Payments Due Year Five

LesseeOperatingLeaseLiabilityPaymentsDueYearFive

120359000

usd

CY2023Q1

us-gaap

Lessee Operating Lease Liability Payments Due

LesseeOperatingLeaseLiabilityPaymentsDue

241440000

usd

CY2023Q1

us-gaap

Lessee Operating Lease Liability Undiscounted Excess Amount

LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

45986000

usd

CY2023Q1

ste

Operatingleaselongandshorttermliabilitycombined

195454000

usd

CY2023Q1

us-gaap

Operating Lease Weighted Average Remaining Lease Term1

OperatingLeaseWeightedAverageRemainingLeaseTerm1

P10Y3M18D

CY2022Q1

us-gaap

Operating Lease Weighted Average Remaining Lease Term1

OperatingLeaseWeightedAverageRemainingLeaseTerm1

P9Y7M6D

CY2023Q1

us-gaap

Operating Lease Weighted Average Discount Rate Percent

OperatingLeaseWeightedAverageDiscountRatePercent

0.033

CY2022Q1

us-gaap

Operating Lease Weighted Average Discount Rate Percent

OperatingLeaseWeightedAverageDiscountRatePercent

0.034

CY2023

ste

Amortizationandimpairmentofacquiredintangibleassets

376822000

usd

CY2022

ste

Amortizationandimpairmentofacquiredintangibleassets

366434000

usd

CY2021

ste

Amortizationandimpairmentofacquiredintangibleassets

83892000

usd

CY2023

us-gaap

Business Combination Acquisition Related Costs

BusinessCombinationAcquisitionRelatedCosts

24196000

usd

CY2022

us-gaap

Business Combination Acquisition Related Costs

BusinessCombinationAcquisitionRelatedCosts

205788000

usd

CY2021

us-gaap

Business Combination Acquisition Related Costs

BusinessCombinationAcquisitionRelatedCosts

35634000

usd

CY2023

ste

Redomiciliationcosts

661000

usd

CY2022

ste

Redomiciliationcosts

301000

usd

CY2021

ste

Redomiciliationcosts

1592000

usd

CY2023

ste

Lossgainonfairvaluecontingentconsiderationadjustments

-3100000

usd

CY2022

ste

Lossgainonfairvaluecontingentconsiderationadjustments

-2350000

usd

CY2022

us-gaap

Stock Repurchased During Period Shares

StockRepurchasedDuringPeriodShares

108368

shares

CY2021

ste

Lossgainonfairvaluecontingentconsiderationadjustments

-500000

usd

CY2023

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

67000

usd

CY2022

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

874000

usd

CY2021

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

-2030000

usd

CY2023

ste

Amortizationofinventoryandpropertystepuptofairvalue

12254000

usd

CY2022

ste

Amortizationofinventoryandpropertystepuptofairvalue

81804000

usd

CY2021

ste

Amortizationofinventoryandpropertystepuptofairvalue

5600000

usd

CY2023

ste

Covid19incrementalcosts

COVID19incrementalcosts

0

usd

CY2022

ste

Covid19incrementalcosts

COVID19incrementalcosts

0

usd

CY2021

ste

Covid19incrementalcosts

COVID19incrementalcosts

25793000

usd

CY2023

us-gaap

Restructuring Charges

RestructuringCharges

485000

usd

CY2022

us-gaap

Restructuring Charges

RestructuringCharges

48000

usd

CY2021

us-gaap

Restructuring Charges

RestructuringCharges

-3029000

usd

CY2023

us-gaap

Goodwill Impairment Loss

GoodwillImpairmentLoss

490565000

usd

CY2022

us-gaap

Goodwill Impairment Loss

GoodwillImpairmentLoss

0

usd

CY2021

us-gaap

Goodwill Impairment Loss

GoodwillImpairmentLoss

0

usd

CY2023

us-gaap

Operating Income Loss

OperatingIncomeLoss

268185000

usd

CY2022

us-gaap

Operating Income Loss

OperatingIncomeLoss

425618000

usd

CY2021

us-gaap

Operating Income Loss

OperatingIncomeLoss

548368000

usd

CY2023Q1

us-gaap

Assets

10821839000

usd

CY2022Q1

us-gaap

Assets

11423594000

usd

CY2023

us-gaap

Payments To Acquire Productive Assets

PaymentsToAcquireProductiveAssets

361969000

usd

CY2022

us-gaap

Payments To Acquire Productive Assets

PaymentsToAcquireProductiveAssets

287563000

usd

CY2021

us-gaap

Payments To Acquire Productive Assets

PaymentsToAcquireProductiveAssets

239262000

usd

CY2023

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

552897000

usd

CY2022

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

553104000

usd

CY2021

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

219237000

usd

CY2023Q1

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

1705512000

usd

CY2022Q1

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

1552576000

usd

CY2023

us-gaap

Revenues

4957839000

usd

CY2022

us-gaap

Revenues

4585064000

usd

CY2021

us-gaap

Revenues

3107519000

usd

CY2023

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

99706000

shares

CY2022

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

97535000

shares

CY2021

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

85203000

shares

CY2023

us-gaap

Weighted Average Number Diluted Shares Outstanding Adjustment

WeightedAverageNumberDilutedSharesOutstandingAdjustment

540000

shares

CY2022

us-gaap

Weighted Average Number Diluted Shares Outstanding Adjustment

WeightedAverageNumberDilutedSharesOutstandingAdjustment

791000

shares

CY2021

us-gaap

Weighted Average Number Diluted Shares Outstanding Adjustment

WeightedAverageNumberDilutedSharesOutstandingAdjustment

695000

shares

CY2023

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

100246000

shares

CY2022

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

98326000

shares

CY2021

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

85898000

shares

CY2023Q1

us-gaap

Preferred Stock Shares Authorized

PreferredStockSharesAuthorized

50000000

shares

CY2023Q1

us-gaap

Preferred Stock Par Or Stated Value Per Share

PreferredStockParOrStatedValuePerShare

0.001

CY2023Q1

ste

Deferred Ordinary Shares

DeferredOrdinaryShares

25000

shares

CY2019Q2

us-gaap

Stock Repurchase Program Authorized Amount1

StockRepurchaseProgramAuthorizedAmount1

78979000

usd

CY2019Q3

us-gaap

Stock Repurchase Program Authorized Amount1

StockRepurchaseProgramAuthorizedAmount1

300000000

usd

CY2023Q1

us-gaap

Stock Repurchase Program Authorized Amount1

StockRepurchaseProgramAuthorizedAmount1

13932000

usd

CY2023

us-gaap

Stock Repurchased During Period Shares

StockRepurchasedDuringPeriodShares

1563983

shares

CY2023

ste

Ordinary Stock Repurchases Not Including Shares Withheldfor Taxes

OrdinaryStockRepurchasesNotIncludingSharesWithheldforTaxes

295000000

usd

CY2022

ste

Ordinary Stock Repurchases Not Including Shares Withheldfor Taxes

OrdinaryStockRepurchasesNotIncludingSharesWithheldforTaxes

25000000

usd

CY2021

us-gaap

Stock Repurchased During Period Shares

StockRepurchasedDuringPeriodShares

35000

shares

CY2021

ste

Ordinary Stock Repurchases Not Including Shares Withheldfor Taxes

OrdinaryStockRepurchasesNotIncludingSharesWithheldforTaxes

5047000

usd

CY2023

us-gaap

Shares Paid For Tax Withholding For Share Based Compensation

SharesPaidForTaxWithholdingForShareBasedCompensation

79169

shares

CY2023

us-gaap

Payments Related To Tax Withholding For Share Based Compensation

PaymentsRelatedToTaxWithholdingForShareBasedCompensation

13534000

usd

CY2022

us-gaap

Shares Paid For Tax Withholding For Share Based Compensation

SharesPaidForTaxWithholdingForShareBasedCompensation

244395

shares

CY2022

us-gaap

Payments Related To Tax Withholding For Share Based Compensation

PaymentsRelatedToTaxWithholdingForShareBasedCompensation

30775000

usd

CY2021

us-gaap

Shares Paid For Tax Withholding For Share Based Compensation

SharesPaidForTaxWithholdingForShareBasedCompensation

91567

shares

CY2021

us-gaap

Payments Related To Tax Withholding For Share Based Compensation

PaymentsRelatedToTaxWithholdingForShareBasedCompensation

9599000

usd

CY2023Q2

us-gaap

Stock Repurchase Program Authorized Amount1

StockRepurchaseProgramAuthorizedAmount1

500000000

usd

CY2023Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant

ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

2794795

shares

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

0.0244

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

0.0110

CY2021

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

0.0046

CY2023

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1

SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

P5Y10M24D

CY2022

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1

SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

P5Y10M24D

CY2021

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1

SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

P6Y

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

0.0080

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

0.0095

CY2021

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

0.0096

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate

0.2449

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate

0.2427

CY2021

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate

0.2304

CY2023

ste

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate

0.0254

CY2022

ste

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate

0.0285

CY2021

ste

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate

0.0278

CY2022Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

1560954

shares

CY2022Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

138.37

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod

235435

shares

CY2023

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

247.45

CY2023

us-gaap

Stock Issued During Period Shares Stock Options Exercised

StockIssuedDuringPeriodSharesStockOptionsExercised

37732

shares

CY2023

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

50.86

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod

8928

shares

CY2023

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice

205.25

CY2023Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

1749729

shares

CY2023Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

154.60

CY2023

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

P6Y2M12D

CY2023Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

83950000

usd

CY2023Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

1124664

shares

CY2023Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

122.41

CY2023

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

P5Y2M12D

CY2023Q1

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

79561000

usd

CY2023Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber

614758

shares

CY2023Q1

ste

Common Stock Fair Market Value Per Share

CommonStockFairMarketValuePerShare

191.28

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

52952000

usd

CY2021

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

39055000

usd

CY2023

us-gaap

Proceeds From Stock Options Exercised

ProceedsFromStockOptionsExercised

1828000

usd

CY2022

us-gaap

Proceeds From Stock Options Exercised

ProceedsFromStockOptionsExercised

10071000

usd

CY2021

us-gaap

Proceeds From Stock Options Exercised

ProceedsFromStockOptionsExercised

26726000

usd

CY2023

us-gaap

Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options

EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions

4945000

usd

CY2022

us-gaap

Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options

EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions

18143000

usd

CY2021

us-gaap

Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options

EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions

11559000

usd

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

50.72

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

37.52

CY2021

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

27.66

CY2022Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

33677

shares

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

13884

shares

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod

16335

shares

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod

2684

shares

CY2023Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

28542

shares

CY2023Q1

us-gaap

Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized

EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

64814000

usd

CY2023

us-gaap

Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1

EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

P2Y1M6D

CY2022Q1

us-gaap

Product Warranty Accrual

ProductWarrantyAccrual

14108000

usd

CY2021Q1

us-gaap

Product Warranty Accrual

ProductWarrantyAccrual

9406000

usd

CY2020Q1

us-gaap

Product Warranty Accrual

ProductWarrantyAccrual

7381000

usd

CY2023

us-gaap

Standard Product Warranty Accrual Additions From Business Acquisition

StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition

0

usd

CY2022

us-gaap

Standard Product Warranty Accrual Additions From Business Acquisition

StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition

4769000

usd

CY2021

us-gaap

Standard Product Warranty Accrual Additions From Business Acquisition

StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition

0

usd

CY2023

us-gaap

Product Warranty Accrual Warranties Issued

ProductWarrantyAccrualWarrantiesIssued

13268000

usd

CY2022

us-gaap

Product Warranty Accrual Warranties Issued

ProductWarrantyAccrualWarrantiesIssued

12571000

usd

CY2021

us-gaap

Product Warranty Accrual Warranties Issued

ProductWarrantyAccrualWarrantiesIssued

10574000

usd

CY2023

us-gaap

Standard Product Warranty Accrual Payments

StandardProductWarrantyAccrualPayments

13693000

usd

CY2022

us-gaap

Standard Product Warranty Accrual Payments

StandardProductWarrantyAccrualPayments

12638000

usd

CY2021

us-gaap

Standard Product Warranty Accrual Payments

StandardProductWarrantyAccrualPayments

8549000

usd

CY2023Q1

us-gaap

Product Warranty Accrual

ProductWarrantyAccrual

13683000

usd

CY2022Q1

us-gaap

Product Warranty Accrual

ProductWarrantyAccrual

14108000

usd

CY2021Q1

us-gaap

Product Warranty Accrual

ProductWarrantyAccrual

9406000

usd

CY2022Q1

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-209808000

usd

CY2021Q1

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-61243000

usd

CY2023

us-gaap

Equity Securities Fv Ni Gain Loss

EquitySecuritiesFvNiGainLoss

-1176000

usd

CY2022

us-gaap

Equity Securities Fv Ni Gain Loss

EquitySecuritiesFvNiGainLoss

-775000

usd

CY2021Q1

us-gaap

Business Combination Contingent Consideration Liability

BusinessCombinationContingentConsiderationLiability

19642000

usd

CY2021Q2

ste

Contingent Consideration Liability Assumed In Cantel Combination

ContingentConsiderationLiabilityAssumedInCantelCombination

25000000

usd

CY2022Q1

us-gaap

Business Combination Contingent Consideration Liability

BusinessCombinationContingentConsiderationLiability

10550000

usd

CY2023Q1

us-gaap

Business Combination Contingent Consideration Liability

BusinessCombinationContingentConsiderationLiability

15678000

usd

CY2020Q1

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-235463000

usd

CY2023

us-gaap

Other Comprehensive Income Loss Before Reclassifications Before Tax

OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax

-110437000

usd

CY2022

us-gaap

Other Comprehensive Income Loss Before Reclassifications Before Tax

OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax

-144212000

usd

CY2021

us-gaap

Other Comprehensive Income Loss Before Reclassifications Before Tax

OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax

177548000

usd

CY2023

us-gaap

Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax

ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax

465000

usd

CY2022

us-gaap

Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax

ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax

4353000

usd

CY2021

us-gaap

Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax

ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax

3328000

usd

CY2023

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

-110902000

usd

CY2022

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

-148565000

usd

CY2021

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

174220000

usd

CY2023Q1

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-320710000

usd

CY2022Q1

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-209808000

usd

CY2021Q1

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-61243000

usd

Name	View Source	Status
0001757898-23-000005-index-headers.html	Edgar Link	pending
0001757898-23-000005-index.html	Edgar Link	pending
0001757898-23-000005.txt	Edgar Link	pending
0001757898-23-000005-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ste-20230331.htm	Edgar Link	pending
ste-20230331.xsd	Edgar Link	pending
ste03312023ex1016.htm	Edgar Link	pending
ste03312023ex1017.htm	Edgar Link	pending
ste03312023ex1024.htm	Edgar Link	pending
ste03312023ex211.htm	Edgar Link	pending
ste03312023ex231.htm	Edgar Link	pending
ste03312023ex241.htm	Edgar Link	pending
ste03312023ex311.htm	Edgar Link	pending
ste03312023ex312.htm	Edgar Link	pending
ste03312023ex321.htm	Edgar Link	pending
ste-20230331_cal.xml	Edgar Link	unprocessable
ste-20230331_def.xml	Edgar Link	unprocessable
ste-20230331_lab.xml	Edgar Link	unprocessable
ste-20230331_pre.xml	Edgar Link	unprocessable
ste-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$STE
STERIS plc Stock $ste

2023 Q2 Form 10-K Financial Statement

#000175789823000005 Filed on May 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STE STERIS plc Stock $ste

2023 Q2 Form 10-K Financial Statement

#000175789823000005 Filed on May 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STE
STERIS plc Stock $ste